Document:

Lease Agreement

 Exhibit 10.40 
 LEASE AGREEMENT 
 THIS AGREEMENT
(“Lease”), made the 19th day of January two thousand and seven (2007), by and between PAINTERS’
CROSSING THREE ASSOCIATES, L.P., (hereinafter called Landlord”), of the one part, and ENDO PHARMACEUTICALS INC., (hereinafter called “Tenant”), a Corporation, (incorporated in Delaware), of the other part. 
 1. DEMISED PREMISES. 
 Landlord
does hereby demise and let unto Tenant the Lot with folio #04-00-00349-05,containing approximately plus/minus four and three thousand two hundred forty one-thousandths (4.3241+/-) acres (“Land”), 300 Endo Blvd., in the
Painters’ Crossing Office Campus including a building to be constructed thereon, in accordance with Paragraph 8 hereof, to be known as Painter’s Crossing Three Building (“Building”) consisting of approximately 48,600 square feet
as shown on Exhibit “A” attached hereto and made a part hereof (“Land” and “Building” are hereinafter collectively referred to as the “Demised Premises”) in the Township of Chadds Ford, the County of Delaware,
in the Commonwealth of Pennsylvania, to be used and occupied as office space and for no other purpose. 
 2. TERM. 

a. Term. The Lease shall be for a term of ten (10) years
(hereinafter called “Demised Term”) beginning on the “Commencement Date”, as hereinafter defined, and ending on the last day of the 120th full month following the Commencement Date (“Expiration Date”), at the rent as hereinafter set forth. 
 b. Commencement Date. The Commencement Date shall be on or after April 1, 2008, when Landlord delivers possession of the
Demised Premises with a substantially completed Building to Tenant. 
 If the Commencement Date would be on a Saturday, Sunday
or a holiday, the Commencement Date shall be the first business day following such Saturday, Sunday or holiday. Within thirty (30) days after the Commencement Date, the parties shall confirm in writing the Commencement Date and the Expiration
Date. 
 c. Substantial Completion. “Substantially Completed” shall mean: (I) the completion of
improvements to the Demised Premises in accordance with the Plans (“Improvements”) so that: (a) Tenant can use the Demised Premises for its intended 

  

					
		  	Endo Pharmaceuticals Inc.	  	Page 1
		  	Confidential	  	

 
purposes, and (b) the incomplete items shall be minor (for example, touch up plastering and painting of walls and ceilings, missing, chipped or broken
fixtures, carpet repair or cleaning, mechanical adjustments to HVAC system and other similar Punchlist items); (ii) the Landlord has obtained a permanent certificate of occupancy; (iii) the Common Area Facilities are fully usable by tenant
and (iv) the Demised Premises is in broom clean condition. 
 d. Inspection and Punchlist. After notice from
Landlord of Substantial Completion, the parties shall inspect the Demised Premises and prepare a Punchlist of any items not completed in accordance with the Plans. Landlord will cause the contractor to complete the items on the Punchlist within
thirty (30) days after the Commencement Date, provided that workmen and the necessary materials are available, but in no event shall such completion take longer than sixty (60) days; except for items which are incomplete because of special
order requested by Tenant, and Landlord shall complete such special order items within thirty (30) days of receipt. This section does not apply to change order items. If such Punchlist items are not completed within sixty (60) days, Tenant
may complete such items and bill Landlord for the cost. Landlord will be required to reimburse Tenant within thirty (30) days of receipt of such bill. 
 e. Notice. Landlord shall give Tenant ten (10) days notice of the estimated Substantial Completion date if it will be different from April 1, 2008. If the estimated Substantial Completion date changes
at any time after Landlord has previously given notice, then Landlord shall give an additional ten (10) days advance written notice of the new estimated Substantial Completion date with the corresponding extension of time. In the case of an
emergency causing delays in the last ten (10) days prior to the Commencement Date, Landlord shall give such notice as is reasonably possible. 
 3. SECURITY DEPOSIT. 
 The Tenant has deposited with the Landlord, at the signing of this Lease, the sum of Two
Hundred Seven Thousand Seven Hundred Sixty Five and 00/100 Dollars ($207,765.00) as security for the full and faithful performance by the Tenant of all the terms of this Lease required to be performed by the Tenant. The Landlord may not commingle
the Security Deposit with its other funds or monies. Landlord shall establish an interest-bearing account on behalf of Tenant and shall deposit Tenant’s security deposit in such account. The security deposit, plus interest, shall be returned to
the Tenant after the expiration of this Lease, provided the Tenant has fully and faithfully carried out all of its terms. In the event of a bona fide sale of the Demised Premises, the Landlord shall have the right to transfer such security deposit
to the purchaser to be held under the terms of this Lease, and the Landlord shall be released from all liability for the return of such security deposit to the Tenant. 
  

					
		  	Endo Pharmaceuticals Inc.	  	Page 2
		  	Confidential	  	

 4. ANNUAL BASE RENT. 
 During the first five (5) years of the Demised Term, the Annual Base Rent shall be One Million Two Hundred Forty Six Thousand Five Hundred Ninety and
00/100 Dollars ($1,246,590.00) lawful money of the United States of America, payable in monthly installments in advance during the said term of this Lease, or any renewal hereof, in sums of One Hundred Three Thousand Eight Hundred Eighty Two and
50/100 Dollars ($103,882.50) on the first day of each month, rent to begin on the Commencement Date. Rent due and payable without demand, or offset at the office of Landlord (Attention: Accounting Department). 
 During the last five (5) years of the Demised Term, the Annual Base Rent shall be One Million Four Hundred Fifty Five Thousand Five Hundred Seventy
and 00/100 Dollars ($1,455,570.00) lawful money of the United States of America, payable in monthly installments in advance during the said term of this Lease, or any renewal hereof, in sums of One Hundred Twenty One Thousand Two Hundred Ninety
Seven and 50/100 ($121,297.50) on the first day of each month, rent to begin on the first day after five (5) years following the Commencement Date. Rent due and payable without demand, or offset at the office of Landlord (Attention: Accounting
Department). 
 5. ESCALATION. 
 If Landlord’s Operating Expense for any Operating Year shall be greater than the Operating Expense Allowance up to Four and 15/100 Dollars ($4.15) per square foot Tenant shall pay to Landlord as additional rent
the Operating Expense Adjustment, being the difference between the Operating Expense and the Operating Expense Allowance. If Tenant occupies the Demised Premises or portion thereof for less than a full Operating Year, the Operating Expense
Adjustment will be calculated in proportion to the amount of time in such Operating Year that Tenant occupied the Demised Premises. 
 Such
Operating Expense Adjustment shall be paid in the following manner: within one hundred twenty (120) days following the last day of the first and each succeeding Operating Year (“Expense Adjustment Date”), Landlord shall furnish Tenant
an Operating Expense Statement as defined below. Within thirty (30) days following the receipt of such Operating Expense Statement, Tenant shall 

  

					
		  	Endo Pharmaceuticals Inc.	  	Page 3
		  	Confidential	  	

 
pay to Landlord as additional rent the Operating Expense Adjustment, if any, for such previous Operating Year. Commencing with the first month of the second
Operating Year and each year thereafter, Tenant shall be obligated to pay to Landlord, on account of the Operating Expense Adjustment for such Operating Year, monthly installments in advance equal to one twelfth (1/12th) of Landlord’s estimate of the Operating Expense Adjustment for such Operating Year (“Estimated Operating
Expense Adjustment”). Landlord shall provide Tenant with the Estimated Operating Expense Adjustment for the current year at the same time as Landlord provides Tenant with the Operating Expense Statement for the prior year. In the event that
Tenant has not received the Estimated Operating Expense Adjustment statement prior to the commencement of the third month of the Operating Year, Tenant shall continue to pay the previous year’s Operating Expense Adjustment. However, Tenant
shall be obligated to pay Landlord’s invoice for the monthly installment of Estimated Operating Expense Adjustment for the third month of the Operating Year (and the fourth month, if the Estimated Operating Expense Adjustment is not delivered
by Landlord to Tenant before the beginning of the fourth month) within fifteen (15) days after delivery of the invoice for the Estimated Operating Expense Adjustment payments throughout the Operating Year and shall pay the eleventh and twelfth
installments of the Operating Expense Adjustment during the first and second months of the succeeding Operating Year. On the next succeeding Expense Adjustment Date, Tenant shall pay to Landlord (or Landlord shall credit to Tenant) any deficiency
(or excess) between the installments paid on account of the preceding year’s Estimated Operating Expense Adjustment and the actual Operating Expense Adjustment for such Operating Year. 
 As used in this Paragraph 5 and Section 1 (Reference Data) where applicable, the following words and terms shall be defined as hereinafter set
forth: 
 a. Operating Year. Shall mean each calendar year, or such other period of twelve (12) months as
hereafter may be adopted by Landlord as its fiscal year, occurring during the Demised Term. 
 b. Operating Expense
Allowance. Shall mean Two Hundred One Thousand Six Hundred Ninety and 00/100 Dollars ($201,690.00) per year, Four and 15/100 Dollars ($4.15) per square foot An estimate of the first year’s operating costs is attached hereto as Exhibit
“B”. 
 c. Operating Expense Statement. Shall mean a statement in writing signed by Landlord, setting forth
in reasonable detail (1) the Operating Expense for the preceding Operating Year, (2) the Operating Expense Allowance and (3) the Tenant’s Operating Expense Adjustment for such Operating Year, if any, or portion thereof. The
Operating Expense Statement shall constitute a final determination as between Landlord and Tenant of the Operating Expense and the Operating Expense Adjustment for any Operating Year. 
  

					
		  	Endo Pharmaceuticals Inc.	  	Page 4
		  	Confidential	  	

 d. Operating Expense. Shall mean the following expenses incurred by Landlord in
connection with the operation, repair and maintenance of the Building and Land of which the Demised Premises is a part: 
 1.
Wages, salaries, fees and other compensation and payments and payroll taxes and contributions to any social security, unemployment insurance, welfare, pension or similar fund and payments for other fringe benefits required by law or by union
agreement (or, if the employees or any of them are nonunion, then payments for benefits comparable to those generally required by union agreement in first-class office buildings in the Philadelphia suburban area, which are unionized) made to or on
behalf of all employees of Landlord performing services rendered in connection with the operation, maintenance, management and administration of the Building and the Land, which Landlord is obligated to perform under Paragraph 18(c) hereof and
including, without limitation, payments made directly to or through independent contractors for performance of such services. 
 2. Maintenance and repair costs, repairs and replacements of building supplies and equipment, for the Land, including sidewalks and parking lots, all snow and rubbish removal, paving (including parking lots) and lawn and grounds landscape
care, maintenance and upkeep and the costs of all labor, supplies, equipment and materials incidental thereto. 
 3. Real
estate taxes and other taxes or charges levied in lieu of such taxes, general and special public assessments, charges imposed by any governmental authority pursuant to anti-pollution or environmental legislation, taxes on the rentals of the
Building, or the use, occupancy or renting of space therein. 
 4. Premiums and fees for fire and extended coverage insurance,
insurance against loss of rentals for space in the building of which the Demised Premises is a part and public liability insurance, all in amounts and coverages (with additional policies against additional risks) as may be required by Landlord or
the holder of any mortgage on the building of which the Demised Premises is a part. 
 5. Water and sewer service charges and
other utility charges for the Demised Premises. 
  

					
		  	Endo Pharmaceuticals Inc.	  	Page 5
		  	Confidential	  	

 6. Management fees in the amount of two percent (2%) payable to the managing agent
for the building, if any, and if there shall be no managing agent or if the managing agent is a company affiliated with Landlord, the management fees that would customarily be charged for the management of the building by an independent, first-class
managing agent in the Philadelphia suburban area. 
 7. The cost of operating and maintaining any sprinkler system installed
to protect the Building. 
 8. Any regular or special assessments levied against the Building pursuant to any Declaration of
Protective Covenants and Easements now or hereafter affecting the Land and any and all expenditures of Landlord in connection with the operation, repair or maintenance of the Land or the Building, which are a Landlord’s obligation pursuant to
Paragraph 18(c) hereof, which are proper expenses in accordance with generally accepted accounting principles consistently applied with respect to the operation, repair and maintenance of the first-class office buildings in the Philadelphia suburban
area. 
 Operating Expense shall be “net” and, for that purpose, shall be reduced by the amounts of: 1) any reimbursement or credit
received or receivable by Landlord with respect to an item of cost that is included in Operating Expense (other than reimbursements to Landlord by Tenant pursuant to Operating Expense escalation provisions) and 2) any cash, trade, or quantity
discounts received by Landlord in connection with the purchase of any goods, utilities, or services in connection with the operation of the Demised Premises. 
 To the extent that any item of Operating Expense is incurred in common with another building or lot in the same office park of Landlord, such items of expense shall be apportioned equitably among the properties in
such office park. 
 If Landlord shall eliminate the payment of any wages or other labor costs or otherwise reduce the Operating Expense as a
result of the installation of new devices or equipment, or by any other means, then in computing the Operating Expense the corresponding items shall be deducted from the Operating Expense Allowance for the Operating Year. 
 e. Operating Expense Exclusions. Notwithstanding the foregoing, “Operating Expense” shall not include expenditures for
any of the following: 
 1. The cost of any capital addition made to the Building. 
  

					
		  	Endo Pharmaceuticals Inc.	  	Page 6
		  	Confidential	  	

 2. Replacements, repairs or other work occasioned by fire, windstorm or other insured
casualty or hazard, to the extent that Landlord shall receive proceeds of such insurance. 
 3. Leasing commissions,
advertising expenses and other costs incurred in leasing or procuring new tenants. 
 4. Repairs or rebuilding necessitated by
condemnation. 
 5. Depreciation and amortization of the Building of which the Demised Premises is a part. 
 6. The salaries and benefits of executive officers of Landlord, if any. 
 7. All utilities other than water and sewer for the Demised Premises. 
 8. All costs and expenses for the Tenant Assumed Duties as defined in Paragraph 18(d). 
 6. ADDITIONAL RENT. 
 a. Tenant agrees to pay as rent in addition to the Annual Base Rent herein reserved any and all sums which may become due by reason of Tenant’s breach of Lease or the failure of Tenant to comply with all of the covenants of this Lease,
especially, but not limited to the Tenant Assumed Duties set forth in Paragraph 18(d) and any and all damages, costs and expenses, including attorney’s fees, which the Landlord may suffer or incur by reason of any default of the Tenant or
failure on Tenant’s part to comply with the covenants of this Lease. 
 b. Tenant further agrees to pay to Landlord as
additional rent all sums due for repairs made to the Demised Premises, replacing of glass windows, doors, partitions, electric wiring and electric lamps, etc., the keeping of waste and drain pipes open and repairs and replacements to wash basins and
plumbing, heating and air-conditioning apparatus, which are necessitated by or caused by misuse or abuse by Tenant, its agents, employees, contractees, visitors and licensees. The same shall be paid by Tenant to Landlord within fifteen
(15) days after presentation by Landlord to Tenant of bills therefor. 
 c. Landlord will provide one initial lamping
upon occupancy of the space by Tenant. 
  

					
		  	Endo Pharmaceuticals Inc.	  	Page 7
		  	Confidential	  	

 7. TIME AND PLACE OF PAYMENT. 
 Unless provided otherwise herein, all Annual Base Rent shall be payable in advance without prior notice or demand and without any set off whatsoever at
the office of Landlord (or at such other place as Landlord may from time to time designate by notice in writing) and at the times provided for the payment of the Annual Base Rent as set forth above in Paragraph 4. All payments of rent by Tenant may
be applied to Base Rent, additional rent, interest or penalties, if any, as Landlord deems appropriate. With respect to additional rent, if any owed by Tenant, Tenant shall pay such additional rent within fifteen (15) days of receipt of a bill
from Landlord for such rent. 
 8. IMPROVEMENT OF DEMISED PREMISES. 
 a. Landlord’s Work. Landlord shall complete and prepare the Demised Premises for Tenant’s initial occupancy in a good and
workmanlike manner in accordance with Building Plans (Exhibit “C”) to be attached hereto when completed utilizing a general contractor selected by Landlord. Exhibit “C” shall be initialed for acceptance by both Landlord and
Tenant when completed. 
 b. Materials Used. Landlord shall use materials as outlined on a Schedule of Construction
Specifications and Finishes for the completion of the Building Shell (Exhibit “D”), attached hereto and initialed for acceptance by both Landlord and Tenant. Any construction other than the Building Shell, shall be Tenant Fit-Up subject to
the Tenant Fit-Up Allowance set forth below. Landlord reserves the right, however in the Building Shell and Tenant fit-up: (1) to make substitutions of material of equivalent grade and quality when and if any specified material shall not be
readily and reasonably available, and (2) to make changes necessitated by conditions met in the course of construction, provided that Tenant’s approval of any change shall first be obtained (which approval shall not be unreasonably
withheld) so long as there shall be general conformity with the Building plans and the Architectural Documents (as defined below) and Tenant’s intended use of the Demised Premises. Tenant’s approval must be given or denied (with reasons
stated in the case of denial) within forty-eight (48) hours after request or approval shall be conclusively deemed to have been given. 
  

					
		  	Endo Pharmaceuticals Inc.	  	Page 8
		  	Confidential	  	

 c. Architectural Construction Documents. Tenant shall supply Landlord, for
Landlord’s approval (which approval shall not be unreasonably withheld), a full set of Architectural Construction Documents (“Architectural Documents”) detailing Tenant’s Fit-Up of the Building Shell. Such Architectural Documents
must be received by Landlord on or before April 1, 2007. The late submission of the Architectural Documents or changes in the Tenant Fit-Up requested after submission of the Architectural Documents by Tenant, may result in delaying the
completion of the Demised Premises beyond the time set forth in Paragraph 9 hereof. Accordingly, the time set forth in Paragraph 9 for delivery of possession of the Demised Premises shall be extended to compensate for the additional time required to
comply with the late Architectural Documents or changes in the Tenant Fit-Up requested after the submission of the Architectural Documents by Tenant. Such extension of time shall not be less than the same amount of time as set forth in any
Construction Agreement or Change Order agreed to by Henderson Northeast Corp. and Tenant. Landlord shall not be liable for any damages resulting from the delay in delivery of the Demised Premises caused by the late submission of Architectural
Documents or changes in Tenant Fit-Up requested after the submission of the Architectural Documents by Tenant and the Tenant may not terminate the Lease because of such delay. 
 Tenant shall be obligated to pay any expenses, charges and costs for Tenant Fit-Up and any changes, including redesigns or upgrades, to the Building
Shell necessitated as a result of the requirements of the Architectural Documents, if such expenses, charges and costs exceed the amount of the Tenant Fit-Up Allowance. 
 d. Tenant Fit-up Allowance. Tenant is hereby granted an allowance up to a maximum of Thirty Five and 00/100 Dollars ($35.00) per
square foot to be used for Tenant “Fit-Up” expense (“Tenant Fit-Up Allowance”) based on the Architectural Documents, as may be amended at Landlord’s approval, all of which Fit-Up shall be performed by Landlord. All plans and
specifications prepared by Landlord’s contractors or subcontractors at the direction of Landlord, including, but not limited to, design fees, preliminary fees, engineering plans and construction documents, shall be charged against this
allowance. To the extent that the expense of Tenant Fit-Up and changes, redesigns or upgrades as aforementioned exceeds the allowance, such excess expense shall be the sole responsibility of the Tenant. Tenant shall pay Landlord for such excess
Tenant Fit-Up expense within thirty (30) days after presentation of invoice for such costs by Landlord. 
  

					
		  	Endo Pharmaceuticals Inc.	  	Page 9
		  	Confidential	  	

 e. Landlord and Tenant assign the obligations to comply with the provisions of the
Americans With Disabilities Act and the regulations issued pursuant thereto (collectively the “ADA”) as follows: 
 (1) Tenant agrees to be responsible for compliance of the Demised Premises with the provisions of the ADA, including the removal of the barriers, ensuring access to areas of primary function, providing auxiliary aids and services to persons
with disabilities which are needed for effective communication or for effective use, and compliance with other non-discriminatory requirements of the provisions of the ADA. In the event that Tenant desires to improve, alter or amend the Demised
Premises so as to comply with the provisions of the ADA, Tenant shall so advise Landlord in seeking Landlord’s approval and consent to make such improvements, alterations or amendments to the Demised Premises. 
 Tenant agrees to indemnify and hold the Landlord harmless from and against from any all liabilities, costs, expenses, fines and penalties,
including reasonable attorneys’ fees, that may be asserted against Landlord, including injury or death to persons and damages to property, and the cost of compliance with the provisions of the ADA, arising out of Tenant’s failure to comply
with its obligations under this paragraph. 
 (2) Landlord shall be responsible for the compliance of the parking lot,
entrance to the building and of the common areas to the provisions of the ADA. 
 9. POSSESSION. 
 If the Landlord shall be unable to give possession of the Demised Premises within thirty (30) days after the Commencement Date, because a certificate
of occupancy has not been procured, or for any other reason whatsoever, the payment of rent by Tenant shall not commence until possession of the Demised Premises is given to or the Demised Premises is available for occupancy by the Tenant. The
failure to give possession on the Commencement Date shall not affect the validity of this Lease or the obligations of the Tenant hereunder, except as stated in this paragraph, or extend the Demised Term of this Lease, provided, however, in the event
Landlord is unable to give possession on or before September 1, 2008 then Tenant shall have the option of declaring the Lease terminated by giving Landlord written notification thereof by registered mail on or before September 5, 2008.

 10. ALTERATIONS AND IMPROVEMENTS. 
 a. Tenant will not make any alterations, improvements or additions to or about the Demised Premises, or affix or attach any articles to or
make any holes in or about the Demised Premises or the building of which the Demised Premises is a part without first having submitted plans for same to Landlord for its prior approval. If said plan receives Landlord’s approval, Landlord

  

					
		  	Endo Pharmaceuticals Inc.	  	Page 10
		  	Confidential	  	

 
alone will make or do the same on behalf of Tenant and for Tenant’s benefit, solely at the cost, expense and risk of Tenant unless otherwise provided in
writing. Notwithstanding the foregoing, the parties agree that Tenant may make any non-structural alterations, non-structural improvements or non-structural additions to the Demised Premises that do not exceed $10,000.00 in cost without seeking
and/or receiving Landlord’s approval. All alterations, improvements, additions or fixtures, whether installed, made or placed before or after the execution of this Lease, shall remain upon the Demised Premises at the expiration or earlier
termination of this Lease and become the property of Landlord unless Landlord shall, at the time Landlord approves such alterations give written notice to Tenant to remove the same at the expiration of the Lease term, in which event Tenant shall
remove the same at the expiration of the Lease term and restore the Demised Premises to the same good order and condition in which it now is; provided, however, trade fixtures may be removed if there is no existing default under this Lease.

 b. Tenant will not lay any linoleum, oil cloth, rubber or other air-tight covering upon the floors of the Demised Premises,
nor fasten articles to or drill holes or drive nails or screws into the walls or partitions of the Demised Premises; nor will Tenant paint, paper or otherwise cover or in any way mark, deface or break said walls or partitions; nor make any
attachment to the electric lighting wires of the Demised Premises or building of which the Demised Premises is a part for storing electricity, running electric fans or motors or other purposes; nor will Tenant use any method of heating other than
that provided by Landlord provided that Tenant may make such non-structural alterations, additions, improvements, and/or repairs to the extent that such non-structural alterations, additions, improvements, and/or repairs do not exceed $10,000.00 in
cost. If Tenant desires to have telephone, telegraph or other similar wires and instruments installed on the Demised Premises, he shall notify Landlord, and Landlord will direct where and how the same are to be installed. Landlord reserves at all
times the right to require Tenant to install and use in the Demised Premises such electrical protective devices and to change wires and their placing and arrangement, as Landlord may deem necessary, and further, to require compliance on the part of
all using or seeking access to such wires with such rules as Landlord may establish relating thereto; and further reserves, in the event of non-compliance with such requirements and rules, the right to cut and prevent the use of any wires to which
such non-compliance relates. 
 c. No contract entered into or that may be subsequently entered into by Landlord with Tenant,
relative to any alterations, additions, improvements or repairs, nor the failure of Landlord to make such alterations, additions, improvements or repairs as required by any such contract, nor the making by Landlord or his agents or contractors of
such alterations, additions, improvements or repairs shall in any way affect the payment of the rent or said other charges at the time specified in this Lease. 
  

					
		  	Endo Pharmaceuticals Inc.	  	Page 11
		  	Confidential	  	

 d. Items of a decorative nature, such as small pictures, are not intended to be
prohibited by this paragraph. 
 11. SIGNS. 
 Tenant will not erect or place any sign, advertising matter, lettering, stand, booth, show case, or other matter of any kind in or upon the door, steps, vestibules, outside walls, outside windows or pavements of the
Building . Tenant will not place any sign, advertising matter, lettering, or other matter of any kind upon the doors giving access into the Demised Premises or upon the interior walls of the Building without the prior written approval of Landlord.
Notwithstanding the foregoing, after consultation with Landlord, Tenant may erect or place a sign containing its company logo on the exterior of the building providing it is in accordance with the Township ordinances and Tenant has obtained a permit
therefor, if a permit is required. In addition, with the approval of Landlord, which approval shall not be unreasonably withheld, Tenant may erect a freestanding sign on the exterior of the Premises in accordance with the ordinance of the Township.

 12. MACHINERY, WEIGHTS, LOCKS, INSURANCE RISKS. 
 a. Tenant will not use or operate in the Demised Premises any machinery that is in Landlord’s opinion harmful to the Demised Premises
or Building. Normal office business machines are not intended to be prohibited by this clause. 
 b. Tenant will not place any
weights in any portion of the Demised Premises which are in Landlord’s opinion beyond the safe carrying capacity of the Demised Premises. 
 c. Tenant will not place any additional locks upon any doors of the Demised Premises or permit any duplicate keys to the locks therein to be made unless access and copies are given to Landlord. 
 d. Tenant shall not do or suffer to be done any act, matter or thing, or employ any person as a result of which the fire insurance or any
other insurance now in force or hereafter to be placed on the Demised Premises, or any part thereof, or the building of which the Demised Premises are a part, shall become void or suspended, or whereby the same shall be rated as a more hazardous
risk than at the date of execution of this Lease, or carry or have any benzine or explosive matter of any kind in and about the Demised Premises unless approved in advance in writing by Landlord. 
  

					
		  	Endo Pharmaceuticals Inc.	  	Page 12
		  	Confidential	  	

 13. REMOVAL OF GOODS. 
 a. Tenant will not remove or attempt to remove Tenant’s goods or property from the Demised Premises otherwise than in the ordinary
and usual course of business, without having first paid and satisfied Landlord for all rent which may be due or become due during the entire term of this Lease. 
 14. COVENANTS OF TENANT. 
 Tenant covenants and agrees that it will without demand: 

a. Payment. Pay the rent and all other charges herein reserved as rent on the days and times and at the place that the same are
made payable, without fail, and if Landlord shall at any time or times accept said rent or rent charges after the same shall have become due and payable, such acceptance shall not excuse delay upon subsequent occasions, or constitute or be construed
as a waiver of any of Landlord’s rights. Tenant agrees that any charge or payment herein reserved, included or agreed to be treated or collected as rent and/or any other charges or taxes, expenses, or costs herein agreed to be paid by the
Tenant may be proceeded for and recovered by the Landlord in the same manner as rent due and in arrears. 
 b. Care of
Demised Premises. Keep the Demised Premises in the same good order in which they are when substantially completed as defined in Paragraph 2(c) hereof and inspected in accordance with Paragraph 2(d) hereof, reasonable wear and tear and damage by
accidental fire or other casualty alone excepted. In the event of the failure of Tenant promptly to perform hereunder, Landlord may go upon the Demised Premises and perform such covenants, the cost hereof, at the sole option of Landlord, to be
charged to Tenant as additional and delinquent rent. 
 c. Compliance of Laws. Comply with any requirements of any
state or federal statute or local ordinance or regulation applicable to Tenant’s use of the Demised Premises, and save Landlord harmless from penalties, fines, costs or damages resulting from Tenant’s failure so to do. 
  

					
		  	Endo Pharmaceuticals Inc.	  	Page 13
		  	Confidential	  	

 d. Fire Protection. Use every reasonable precaution against fire. 
 e. Surrender of Demised Premises. Peacefully deliver up and surrender possession of the Demised Premises to Landlord upon the
expiration or earlier termination of this Lease or any renewal thereof in broom clean condition and the same good order and condition in which Tenant is obligated to keep the same during the continuance of this Lease. Tenant will upon the expiration
or earlier termination of this Lease or any renewal thereof remove all of his property from the Demised Premises so that Landlord may again have and repossess the same not later than noon on the day on which this Lease or the renewal thereof shall
terminate or expire and will immediately thereafter deliver to Landlord at its office all keys for the Demised Premises. 
 f.
Notice of Damage. Give to Landlord prompt written notice of any accident, fire, or damage occurring on or to the Demised Premises. 
 g. Janitorial Access. Intentionally deleted. 
 h. Agency for Leasing. Not cause
or allow any agent to represent Tenant in any subletting or reletting of the Demised Premises other than an agent approved by the Landlord, if, with the permission in writing of Landlord, Tenant shall vacate or decide at any time during the Demised
Term to vacate the herein Demised Premises prior to the expiration of this Lease, or any renewal hereof, and that should Tenant do so, or attempt to do so, the Landlord may remove any signs that may be placed on or about the Demised Premises by such
other agent without any liability to Landlord or to said agent, the Tenant assuming all responsibility for such action. 
 15. RULES
AND REGULATIONS. 
 The Rules and Regulations attached hereto as Exhibit “F” in regard to the said Demised Premises and/or
building of which the Demised Premises is a part and the tenants occupying offices therein, and such amendments, additions and modifications thereof as may from time to time be made by Landlord) shall be deemed a part of this Agreement with the same
effect as though written herein, provided such amended Rules and Regulations of operation do not effect Tenant’s rights enumerated in this Lease. Tenant covenants that said Rules and Regulations shall be faithfully observed by Tenant,
Tenant’s employees, and all persons visiting the Demised Premises, or claiming under Tenant, the right being hereby expressly reserved by Landlord to add to, alter or rescind, from time to time, such rules and regulations, which changes in
rules and regulations shall take effect only after ten (10) business days notice thereof in writing by the Landlord to Tenant. 
  

					
		  	Endo Pharmaceuticals Inc.	  	Page 14
		  	Confidential	  	

 16. ASSIGNMENT AND SUBLET. 
 a. Tenant, under penalty of instant forfeiture, shall not assign, mortgage or pledge this Lease, nor underlet or sublease the Demised
Premises or any part thereof without the written consent of Landlord first had and obtained; nor after such written consent has been given shall any assignee or sublessee assign, mortgage or pledge this Lease or such sublease or underlet or sublease
said Demised Premises or any part thereof without an additional written consent by Landlord; and in neither case without such consent shall any such assignment, mortgage, pledge, underletting or sublease be valid. Notwithstanding the foregoing,
Tenant may assign this Lease or sublet the Demised Premises to a parent or subsidiary corporation without first obtaining the consent of Landlord. 
 b. An assignment within the meaning of this Lease is understood and intended to comprehend not only the voluntary action of Tenant, but also the direct or indirect transfer of fifty percent (50%) or more of the
voting stock of a corporate tenant, unless Tenant is publicly traded, or fifty percent (50%) or more of the interest in partnership profits of a partnership Tenant (except by reason of death) of a shareholder or partner, any levy or sale on
execution or other legal process and every assignment for the benefit of creditors, adjudication or sale in bankruptcy or insolvency or under any other compulsory procedure or order of court. 
 c. No assignment or sublease, if consented to in the manner aforesaid, shall in any way relieve or release Tenant from liability upon any
of the covenants under the terms of this Lease, and notwithstanding any such assignment or sublease the, responsibility and liability of Tenant hereunder shall continue in full force and effect until the expiration of the term hereby created and any
renewals thereof. No assignment or sublease shall be valid unless the assignee or subtenant shall assent to and agree in writing to be bound by all of the covenants and conditions herein contained and unless such assignment or sublease is to a party
that will be an actual user of the Demised Premises. 
  

					
		  	Endo Pharmaceuticals Inc.	  	Page 15
		  	Confidential	  	

 17. LANDLORD’S RIGHTS. 
 Tenant covenants and agrees that Landlord shall have the right to do the following things and matters in and about the Demised Premises: 
 a. Access to the Demised Premises. At all reasonable times and upon written notice three (3) business days in advance to
Tenant (except in the case of an emergency, in which event no notice is required), by himself or his duly authorized agents to go upon the Demised Premises without disruption, if reasonably possible, (1) to inspect the same and every part
thereof; (2) for the purpose, at his option, of making repairs, alterations, additions, or improvements thereof; (3) for the purpose of making electrical wiring changes in electric service outlets in floor, ceiling and/or walls;
(4) for the purpose of making adjustments of any nature to the air-conditioning system; (5) for the purpose of fighting fire within the Demised Premises or elsewhere in the Building, or for the control or correction of conditions resulting
from flood, either from a broken pipe or from outside sources; (6) for the purpose of performing any covenants herein contained which Tenant has failed to perform within ten (10) days of Landlord’s written request to do so;
(7) for the purpose of remedying any matter due to breach of covenant of Tenant. 
 b. Showing the Demised
Premises. At any time after notice properly given by either party to the other of an intention to terminate this Lease, and upon forty-eight (48) hours notice to Tenant, to conduct persons who may be interested in leasing the Demised
Premises in and about the same, provided that such showing shall be conducted after Tenant’s business hours. 
 c.
Control of Building. To control and have dominion over the halls, passages, entrances, elevators, toilets, stairways, balconies and roof of the building of which the Demised Premises is a part, the same being not for the use of the general
public; and Landlord shall in all cases have the right to control and prevent access thereto of all persons whose presence in the judgment of Landlord or his agents, shall be prejudicial to the safety, character, reputation and interests of the
building of which the Demised Premises is a part and its tenants. 
 d. Prevention of Access. To prevent access to the
building of which the Demised Premises is a part in the event of invasion, mob, riot, public excitement or other commotion by closing doors or otherwise for the safety of tenants and for the protection of property in the building. 
 18. RESPONSIBILITY OF LANDLORD. 
 a. HVAC. Landlord shall have the HVAC system installed and shall deliver it to Tenant with the completed Building, at which time Tenant shall assume responsibility for the HVAC system pursuant to Paragraph
18(d)(iii) hereof. Provided, however, 

  

					
		  	Endo Pharmaceuticals Inc.	  	Page 16
		  	Confidential	  	

 
at Tenant’s request, Landlord shall take steps to enforce any warranties of workmanship or materials for the HVAC system, and to have repaired by the
manufacturer or installer, any items which require repair pursuant to the warranty of materials or work. 
 b. Landlord
Insurance. Landlord shall maintain and pay for fire and extended coverage insurance on the building of which the Demised Premises is a part in such amounts as Landlord and/or Landlord’s mortgagees shall require. Payments for losses
thereunder shall be made solely to Landlord or the mortgagees of Landlord as their interests shall appear. 
 c. Repairs
and Maintenance. After Tenant has accepted the Demised Premises as set forth in Paragraph 2 hereof, Landlord shall, at its cost, repair all structural defects and latent defects in the construction of the Building, and all defective exterior
windows and glass. At Tenant’s request, Landlord shall take steps to enforce any warranties of workmanship or materials for the Building and Land, and to have repaired by the manufacturer or installer, any items which require repair pursuant to
the warranty of materials or work. In the event that any repair is required by reason of the negligence or abuse of Tenant or its agents, employees, invitees or of any other person using the Demised Premises with Tenant’s consent, express or
implied, if Tenant fails or refuses to make such repair, Landlord may, but shall not be obligated to, make such repair, and shall invoice the cost thereof to Tenant, which invoice will become due within thirty (30) days after presentation or
when the next installment of rent is due, whichever is the later. 
 d. Tenant Assumed Duties. Tenant hereby agrees to
perform, cause to be performed, assumes the obligation to perform and releases Landlord from any obligation to perform, the following duties and responsibilities: 
 (i) All janitorial duties within the Building as specifically set forth on Exhibit “E” to the Lease, as well as the shampooing
of carpeting and appropriate cleaning of floor surfaces in the lobby and central areas of the Building which would generally be considered “common areas” at least every six (6) months, or more often as required to maintain them in
good and safe condition. Provided however, Landlord shall continue to wash the windows, inside and outside, in the Building once annually, or more often if requested by Tenant. 
 (ii) All of the general maintenance, service and repair of the Building , including, but not limited to, windows, doors and glass, all
plumbing, electrical and telephone systems (but excluding the roof and structural components of the Building), in order to maintain the Building in good operational condition and repair and to prevent the diminution in the 

  

					
		  	Endo Pharmaceuticals Inc.	  	Page 17
		  	Confidential	  	

 
expected life of the Building, to contract with such reputable contractors, satisfactory to Landlord, as Tenant deems necessary to maintain, service and
repair the entire Demised Premises in accordance with this Lease. Any interruption in service or performance of any Building system is not a breach of the Lease by Landlord. Notwithstanding the foregoing, Tenant shall not be responsible for repair
of any items under warranty which if Tenant gives timely notice to Landlord of the breach of warranty, will be repaired by the manufacturer or installer pursuant to their warranty of their materials or work. Tenant shall not be responsible for the
repair of those parts of the Demised Premises which Landlord is obligated to repair under the Lease including but not limited to latent defects in the construction of the Building; however, Tenant agrees to give prompt notice of such latent defects
to Landlord when discovered. 
 (iii) Tenant, at its own expense, shall maintain the HVAC for the Building under a contract
with an HVAC repair service acceptable to Landlord (“Maintenance Contract”) and shall provide Landlord with a copy of same. The specifications for the Maintenance Contract are attached hereto as Exhibit “G”. In the event that the
HVAC system, or any part of the HVAC system requires replacement, such replacements shall be at Tenant’s cost and expense. 
 (iv) The maintenance, operation and repair of the fire alarm system and the security system installed for the Building. 
 All of
the foregoing duties (as set forth in Paragraph 18(d)(i – iv) are hereinafter referred to as “Tenant Assumed Duties”. 
 In
assuming the Tenant Assumed Duties, Tenant agrees to perform same, or cause same to be performed, in a good and workmanlike manner and in accordance with the standards in the applicable industry. In the event that Tenant fails to perform the Tenant
Assumed Duties, Landlord may, but shall not be obligated to notify Tenant of Tenant’s default, and, if notice is given, Tenant shall have thirty (30) days, from such notice to perform such duties, except in the case of emergency. At the
expiration of the thirty (30) day period or in the case of emergency, Landlord may, but shall not be obligated to, perform all of any part of the Tenant Assumed Duties on Tenant’s behalf, and the costs of same shall be invoiced to Tenant,
along with a management fees for same, and shall be payable as Additional Rent when the next installment of Rent is due. 
 Further, Tenant
agrees to indemnify and hold the Landlord, its partners, agents, servants and employees, harmless from and against any and all liabilities, costs, expenses, including reasonable attorney’s fees, suits, causes of action, fines and penalties,
including the cost of compliance with the provisions of all laws, ordinances or regulations applicable to the Tenant’s performance 

  

					
		  	Endo Pharmaceuticals Inc.	  	Page 18
		  	Confidential	  	

 
of the Tenant Assumed Duties on or about the Building, that may be asserted against Landlord, its partners, agents, servants and employees, as a result of or
in connection with any injury or death to persons and damages to property, and any other expenses or damages arising out of Tenant’s negligence or failure to fully and faithfully perform its obligations under this Paragraph. 
 In all contracts with third parties and prior to their commencing work on the Demised Premises, Tenant shall obtain from them: (i) certificates of
general liability insurance in such forms as Tenant is required to carry, pursuant to the paragraph “General Liability Insurance Provisions” of the Lease. Such certificates of insurance shall be forwarded to Landlord prior to commencement
of work in the Demised Premises; (ii) executed Waivers of Mechanics’ Liens (except for janitorial service companies). Said Waiver of Liens shall be returned to Landlord with proof that said Waiver of Liens was filed of record prior to
contractor’s commencing work in the Demised Premises, and (iii) all necessary permits for work on the Demised Premises from the state and local authorities. Copies of such permits shall be supplied to Landlord at least forty-eight
(48) hours prior to commencing work on the Demised Premises. 
 19. INDEMNITY AND INSURANCE. 
 a. Indemnity. Tenant agrees to indemnify and to relieve and hereby indemnifies and relieves Landlord from all liability and expense
by reason of any loss, damage or injury to Tenant or any other person or to any property of Tenant or of any other person which may arise from any cause whatsoever on the Demised Premises or on the pavement, curb, roof, sidewalks, elevators,
hallways parking lots, passages or other portions of the Building, except to the extent due to the negligence of Landlord, its agents, servants or employees, Tenant further agrees to indemnify and to relieve and hereby indemnifies and relieves
Landlord from all liability and expense by reason of any loss, damage or injury to Tenant or to any employee or business invitee of Tenant or to any property of Tenant or any employee or business invitee of Tenant which may occur on the pavement,
curb, roof, sidewalks, elevators, hallways, parking lots, passages or other portions (other than the Demised Premises) of the Building, except to the extent due to the negligence of the Landlord, his servants, agents or employees. 
 b. Commercial General Liability Insurance. Tenant shall at all times during the period in which it has any occupancy rights in the
Demised Premises, maintain in full force and effect commercial general liability insurance, naming Landlord and its managing agent, if any, as additional insured covering injury to persons and damage to property occurring in or about the Demised
Premises, in such amounts as may reasonably be required by Landlord from time to 

  

					
		  	Endo Pharmaceuticals Inc.	  	Page 19
		  	Confidential	  	

 
time, but not less than $1,000,000 combined single limit, with a deductible not to exceed Five Thousand Dollars ($5,000.00). Tenant shall deliver to Landlord
duplicate originals or certificates of such insurance at or prior to the date Tenant shall make any entry into the Demised Premises, together with evidence of paid up premiums, and shall deliver to Landlord renewals thereof at least fifteen
(15) days prior to expiration. All such policies of insurance shall be with an insurance company licensed to do business in Pennsylvania, and shall provide that they shall not be cancelled or amended without at least twenty (20) days prior
notice to Landlord. 
 c. Personal Property Insurance. Tenant shall maintain, at its expense, insurance on all of its
personal property, including removable trade fixtures, located in the Demised Premises. 
 d. Certificates of
Insurance. Tenant shall, at Landlord’s request from time to time, provide Landlord with current certificates of insurance evidencing Tenant’s compliance with this Paragraph. 
 e. Waiver of Subrogation. Tenant and Landlord shall obtain the agreement of their insurers to waive all rights of subrogation
against each other with respect to coverages in this Paragraph. 
 20. FIRE OR OTHER CASUALTY. 
 Within thirty (30) days from the date of casualty, Landlord shall notify Tenant whether it intends to restore or repair the Demised Premises within
the time period set forth herein. 
 a. Total or Substantial Destruction. In the event that the Demised Premises is
totally destroyed or so damaged by fire or other casualty not occurring through fault or negligence of the Tenant or those employed by or acting for him, that, in Landlord’s judgment, the same cannot be repaired or restored within one hundred
eighty (180) days, this Lease shall absolutely cease, and the rent shall abate as of the date of casualty for the balance of the term. 
 b. Partial Destruction. If the damage caused as above be only partial and such that the Demised Premises, in Landlord’s judgment, can be restored within one hundred eighty (180) days, the Landlord
may, at its option, restore the same (excluding fixtures and improvements owned by Tenant) with reasonable promptness, reserving the right to enter upon the Demised Premises for that purpose. The Landlord also reserves the right to enter upon the
Demised Premises whenever necessary to repair 

  

					
		  	Endo Pharmaceuticals Inc.	  	Page 20
		  	Confidential	  	

 
damage caused by fire or other casualty to the Building, even though the effect of such entry be to render the Demised Premises or a part thereof
untenantable. In either event the rent shall be apportioned and suspended during the time the Landlord is in possession, taking into account the portion of the Demised Premises rendered untenantable and the duration of the Landlord’s
possession. Tenant agrees to pay the full amount claimed by Landlord. Tenant shall, however, have the right to proceed by law to recover the excess payment, if any, or by arbitration pursuant to the rules of the American Arbitration Association. The
parties agree that the loser in the arbitration shall pay the costs of arbitration. 
 c. Waiver of Damages During
Repair. Landlord shall not be liable for any damages, compensation or claim by reason of inconvenience, annoyance, injury or loss resulting from the termination of this Lease by reason of the destruction of the Demised Premises, from the making
of repairs, alterations, additions or improvements to any portion of the Demised Premises, the Building or the facilities thereof, from any of the services or facilities supplied by Landlord, or from the leaking of rain, snow, water, steam or gas
into, in or about the Demised Premises or the Building t. 
 d. Mortgage Acceleration. In the event that Landlord does
not notify Tenant that, in the Landlord’s judgment, the damage cannot be repaired within one hundred and eighty (180) days, or in the event that Landlord fails to notify Tenant if Landlord exercises its election to repair the damage
within(120)days, then Tenant shall have the right to give notice to Landlord after the expiration of thirty (30) days from the date of damage, that unless Landlord advises Tenant within ten (10) days after receipt of such notice that
Landlord intends to complete the repair of the damage to the Demised Premises within one hundred and eighty (180) days from the date of the damage, it shall be deemed conclusive that Landlord has elected not to complete said repairs, and the
Tenant may elect to terminate the Lease, commencing the eleventh day after such notice, at any time prior to the receipt of notice from Landlord of its election to repair the damage to the Demised Premises. Notwithstanding the fact that Landlord may
have given notice of election to repair the Demised Premises within said thirty (30) day period, if the mortgagee chooses to accelerate the mortgage due to damage by fire or other casualty to the Demised Premises or the Building, Landlord shall
have the right to rescind and/or cancel said election to repair and shall have the right to elect not to repair the damaged to the Demised Premises or the Building , provided said notification of election not to repair is given to Tenant within
thirty (30) days after date of the receipt of said notice of acceleration. 
  

					
		  	Endo Pharmaceuticals Inc.	  	Page 21
		  	Confidential	  	

 e. In the event that Landlord has given notice that it intends to restore or repair the
Demised Premises within one hundred and eighty (180) days and Landlord has caused substantial work to be performed with respect to said restoration or repairs but has not completed the same within one hundred and sixty-five (165) days,
Landlord shall be entitled to extend the time to two hundred and ten (210) days from the date of the casualty by giving Tenant written notice at least one hundred and sixty-five (165) days from the date of the casualty that it requires the
extra thirty (30) days to complete the said restoration or repairs. 
 21. DEFAULT AND REMEDIES. 
 a. Events of Default. If the Tenant: 
 1. Does not pay within five (5) days after due without any set off or deduction any and all installments of rent and/or any other charge or payment herein reserved, included, or agreed to be treated or collected
as rent and/or any other charge, expense, or cost herein agreed to be paid by the Tenant; or 
 2. violates or fails to
perform or otherwise breaches any covenant or agreement herein contained, other than for the payment of money as specified in subparagraph (a)(1) hereof, or as otherwise specified in subparagraphs (3) through (8) hereof and fails to cure
the same within thirty (30) days after written notice thereof by Landlord (or such longer period as is reasonably required to correct any such default, provided Tenant promptly commences and diligently continues to effectuate a cure); or

 3. vacates the Demised Premises or removes or attempts to remove or manifests an intention to remove any goods or property
therefrom otherwise than in the ordinary and usual course of business without having first paid and satisfied the Landlord in full for all rent and other charges then due or that may thereafter become due until the expiration of the then current
term, above mentioned; or 
 4. files a petition under Title II, United States Code, Bankruptcy, as now or hereafter amended
or supplemented, whether under Chapter 7, 11 or 13 of the aforesaid Bankruptcy Code, or has filed against Tenant such a petition and the same is not dismissed within sixty (60) days; 
 5. commences or has commenced against it any action or proceeding under state or federal law for the dissolution or liquidation of the
Tenant in connection with bankruptcy or other insolvency, or for the appointment of a receiver or trustee of all or substantially all of the property of the Tenant, and if filed against Tenant, the action proceeding is not dismissed within sixty
(60) days; 
  

					
		  	Endo Pharmaceuticals Inc.	  	Page 22
		  	Confidential	  	

 6. has possession of property of the Tenant taken by any governmental officer or agency
so as to exclude Tenant from control thereof, or by any trustee, guardian or other appointee pursuant to statutory authority for the dissolution, rehabilitation, reorganization, or liquidation of the Tenant; or 
 7. makes an assignment for the benefit of creditors; or 
 8. has its property levied upon by any Sheriff, Marshall or constable, and said levy is not dismissed within ten (10) days;

 Then and in any of said events, there shall be deemed to be an Event of Default of this Lease. 
 b. Remedies. Upon an Event of Default as aforesaid, Landlord, in addition to all other rights and remedies available to it by law
or equity or by any other provisions hereof, may at any time thereafter: 
 1. Acceleration. Declare to be immediately
due and payable, on account of the rent and other charges herein reserved for the balance of the term of this Lease, a sum equal to the Accelerated Rent Component (as hereinafter defined), and Tenant shall remain liable to Landlord as hereinafter
provided, and/or; 
 2. Accelerated Rent Component. For purposes hereof, the Accelerated Rent Component shall mean the
aggregate of: 
 (i) all rent, additional rent and other charges, payments, costs and expenses due from Tenant to Landlord
and in arrears at the time of the election of Landlord to recover the Accelerated Rent Component; 
 (ii) the rent reserved
for the then entire unexpired balance of the term of this Lease, plus all additional rent and other charges, payments, costs and expenses herein agreed to be paid by Tenant up to the end of said term which shall be capable of precise determination
at the time of Landlord’s election to recover the Accelerated Rent Component, discounted to present value at four percent (4%) below the then existing prime rate of Citibank of 

  

					
		  	Endo Pharmaceuticals Inc.	  	Page 23
		  	Confidential	  	

 
New York (Bank). No estimate of any component of additional rent to accrue pursuant to the provisions of Paragraph 6 of this Lease shall be less than the
amount which would be due if each such component continued at the highest monthly rate or amount in effect during the twelve (12) months immediately preceding the default. 
 3. Termination. Terminate this Lease on at least seven (7) days’ notice to Tenant and, on the date specified in said
notice, this Lease and the term hereby demised and all rights of Tenant hereunder shall expire and terminate and Tenant shall thereupon quit and surrender possession of the Demised Premises to Landlord in the condition elsewhere herein required and
Tenant shall remain liable to Landlord for any obligation or provision which shall survive the termination of this Lease. If Landlord had previously elected to accelerate rent under subparagraph (b)(1) hereof, but has not received complete payment
of the Accelerated Rent Component, Landlord may terminate the lease for any current month for which the applicable Accelerated Rent Component has not been paid. 
 4. Landlord, may, without further notice, enter upon and repossess the Demised Premises, by summary proceedings, ejectment or otherwise,
and may dispossess Tenant and enjoy the Demised Premises and the rents and profits therefrom. Landlord may, in its own name, as agent for Tenant, if this Lease has not been terminated, or in its own behalf, if this Lease has been terminated, relet
the Demised Premises or any part thereof for such term or terms (which may be greater or less than the period which would otherwise have constituted the balance of the term of this Lease) and on such conditions and provisions (which may include
concessions or free rent) as Landlord in its sole discretion may determine. Landlord, may, in connection with any such reletting, cause the Demised Premises to be redecorated, altered, divided, consolidated with other space or otherwise changed or
prepared for reletting. No reletting shall be deemed a surrender and acceptance of the Demised Premises by Landlord. 
 5.
Damages. As a cumulative and alternative remedy of Landlord in the event of termination of this Lease by Landlord following any default by Tenant, Landlord, at its option, shall be entitled to recover damages for such default from the date of
the termination in an amount equal to the Accelerated Rent Component for the balance of the term, determined without regard to the early termination, less the fair rental value of the Demised Premises for the remainder of the original term of the
Lease, discounted to present value at four percent (4%) below the then existing Prime Rate of Bank, and such damages shall be payable by Tenant upon demand. 
  

					
		  	Endo Pharmaceuticals Inc.	  	Page 24
		  	Confidential	  	

 c. Continuing Liability. Tenant shall, with respect to all periods of time up to
and including the expiration of the term or other termination of this Lease, remain liable to Landlord for the rent, additional rent and all other charges payable under this Lease. Tenant shall be entitled to a credit for any portion of the
Accelerated Rent Component paid by Tenant to Landlord. In the event that the property has been relet or sublet by Tenant or Landlord for the benefit of Tenant, and the rent therefor shall be paid directly to Landlord by said new tenant or sublet
tenant, Tenant shall be entitled to a credit against the rent and all other charges paid or payable under this Lease for the net proceeds received by Landlord after deduction of all costs payable by Landlord incidental to such reletting or
subletting. If it shall be determined at the expiration of the term of this Lease that a credit is due Tenant because the net proceeds of reletting, as aforesaid, plus the amounts paid to Landlord by Tenant by Accelerated Rent Component or
otherwise, exceed the aggregate of rent and other charges accrued in favor of Landlord to the end of said term, Landlord shall refund such excess to Tenant, without interest, promptly after such determination, after written request by Tenant.

 d. No Duty to Relet. In no event shall Landlord be responsible or liable for any failure to relet the Demised
Premises or any part thereof, or for any failure to collect any rent due upon a reletting. 
 e. Bankruptcy. Nothing
contained in this Lease shall limit or prejudice the right of Landlord to prove for and obtain as damages incident to a termination of this Lease, in any bankruptcy, reorganization or other court proceedings, the maximum amount allowed by any
statute or rule of law in effect when such damages are to be proved. 
 f. Waiver of Defects. Tenant (further) waives
the right to any notices to quit as may be specified in the Landlord and Tenant Act of Pennsylvania, Act of April 6, 1951, as amended in 1995, and agrees that seven (7) days notice shall be sufficient in any case where a longer period may
be statutorily specified. 
 g. Further Remedies of Landlord. In the event of any default as above set forth in this
paragraph, the Landlord, or anyone acting on Landlord’s behalf, at Landlord’s option: 
 1. May have and exercise
any and all other rights and/or remedies, granted or allowed landlords by existing or future Statute, Act of Assembly, or other law of this state in cases where a landlord seeks to enforce rights arising under a lease agreement against a tenant who
has defaulted or otherwise breached the terms of such lease agreement; and 
  

					
		  	Endo Pharmaceuticals Inc.	  	Page 25
		  	Confidential	  	

 2. May have and exercise any and all other rights and remedies contained in this Lease,
including the rights and remedies provided by paragraphs 22 and 23 hereof. 
 23. ENFORCEMENT. 
 It is hereby covenanted and agreed, any law, usage or custom to the contrary notwithstanding, that Landlord shall have the right at all times to enforce
the covenants and provisions of this Lease in strict accordance with its terms notwithstanding any conduct on the part of the Landlord in refraining from so doing at any time or times; and, further, that the failure of Landlord at any time or times
to enforce its rights under said covenants and provisions strictly in accordance with the same shall not be construed as having created a waiver or custom in any way or manner contrary to the specific terms, provisions and covenants of this Lease or
as having in any way or manner modified the same. 
 24. RIGHT OF ASSIGNEE OF LANDLORD. 
 The right to enforce all the provisions of this Lease herein provided for may at the option of any assignee of this Lease, be exercised by any assignee of
the Landlord’s right, title and interest in this Lease in his, her or their own name, any statute, rule of court, custom, or practice to the contrary notwithstanding. 
 25. REMEDIES CUMULATIVE. 
 All of the remedies hereinbefore given to Landlord and all rights and remedies given to it by law and equity shall be cumulative and concurrent. No determination of this Lease or the taking or recovering of the Demised Premises shall
deprive Landlord of any of its remedies or actions against Tenant for rent or sums due at the time or which, under the terms hereof, would in the future become due as if there has been no termination; nor shall the bringing of any action for rent or
breach of covenant, or the resort to any other remedy herein provided for the recovery of rent be construed as a waiver of the right to obtain possession of the Demised Premises. 
 26. MECHANIC’S LIEN. 
 a. Tenant will not permit any mechanic’s lien or liens to be placed upon the Demised Premises or the building of which the Demised Premises is a part. Nothing in this Lease shall be deemed or construed in any way
as constituting the consent or request of 

  

					
		  	Endo Pharmaceuticals Inc.	  	Page 26
		  	Confidential	  	

 
Landlord, express or implied, to any person for the performance of any labor or the furnishing of any materials to all or part of the Demised Premises, nor
as giving Tenant any right, power, or authority to contract for or permit the rendering of any services or the furnishing thereof that would or might give rise to any mechanic’s or other liens against the Demised Premises or the Building .

 b. If any such lien is claimed against the Demised Premises or Building, then, in addition to any other right or remedy of
Landlord, Landlord may, but shall not be obligated to, discharge the same by payment to the claimant or by posting a bond in Court of Common Pleas in accordance with the rules of court, as Landowner may elect in its sole discretion. Any amount paid
by Landlord for such purposes shall be invoiced to Tenant and paid by Tenant to Landlord as additional rent at the time the next installment of rent is due. 
 27. CONDEMNATION. 
 If at any time during the Demised Term the Demised Premises, or any
portion thereof, be lawfully condemned or conveyed in lieu of condemnation, the Landlord shall be entitled to, and shall receive the award or payment therefor, and the Tenant shall assign, and does hereby assign and transfer to the Landlord such
award or payment as may be made therefor. Tenant, however, shall be entitled to make a separate claim for those damages made payable specifically and solely to a business Tenant under the terms of the Eminent Domain Code of Pennsylvania, Act of
June 22, 1964, P.L. 84, as now or hereafter amended, provided however any award to Tenant shall not in way diminish the Landlord’s award. This Lease shall, as to the part so taken terminate as of the date title shall vest in the condemner,
and rent shall abate in proportion to the square feet of the Demised Premises taken or condemned. If more than thirty (30%) percent of the Demised Premises is so taken, Landlord or Tenant may give notice of its desire to terminate the Lease.
The notice shall be given within thirty (30) days after the condemnation has occurred and the Lease shall terminate thirty (30) days after the date of notice given by Landlord or Tenant to the other. 
 28. ESTOPPEL CERTIFICATE. 
 At any time, and from time to time, upon the written request of Landlord or any mortgagee, Tenant within twenty (20) days of the date of such written request agrees to execute and deliver to Landlord and/or such mortgagee, without
charge and in form satisfactory to Landlord and/or such mortgagee, a written statement (1) ratifying this Lease; (2) confirming the commencement and expiration date of the term of this Lease and the minimum annual rental rate payable
during the lease term; (3) certifying that 

  

					
		  	Endo Pharmaceuticals Inc.	  	Page 27
		  	Confidential	  	

 
Tenant is in occupancy of the Demised Premises, and that the Lease is in full force and effect and has not been modified, assigned, supplemented or amended
except by such writings as shall be stated; (4) certifying that all conditions and agreements under this Lease to be satisfied or performed by Landlord have been satisfied and performed except as shall be stated; (5) certifying that there
is no default by Landlord or Tenant under the Lease and there are no defenses or offsets against the enforcement of this Lease by Landlord or stating the defaults and/or defenses claimed by Tenant; (6) reciting the amount of advance rent, if
any, paid by Tenant and the date to which such rent has been paid and, if requested by Landlord and/or Mortgagee, agreeing that Tenant shall not pay rent to Landlord more than thirty (30) days in advance; (7) reciting the amount of
security deposited with Landlord, if any; (8) certifying that Tenant has no option or right of first refusal to purchase the Demised Premises or option to extend the term of the Lease (unless specifically set forth to the contrary in the
Lease); (9) if requested by Landlord and/or Mortgagee, agreeing that the Lease will not be modified without the prior written consent of the Mortgagee; (10) certifying that Tenant has not and will not generate, store, handle or otherwise
deal with any amount of any hazardous substances or hazardous waste (as defined in federal, state and local law) in or about the Demised Premises, in excess of those levels or quantities specified for regulatory purposes; (11) agreeing, if
requested by Mortgagee, that Tenant will give such Mortgagee such notice of any default by Landlord and reasonable opportunity to cure such default, not in excess of thirty (30) days, unless the default cannot be cured within said time, before
exercising Tenant’s remedies under the Lease; and (12) any other information which Landlord or the mortgagee shall require. 
 Failure to Execute. The failure of Tenant to execute, acknowledge and deliver to Landlord and/or any mortgagee a statement in accordance with the provisions of this paragraph within the said twenty (20) day period shall
constitute acknowledgement by Tenant which may be relied upon by any person holding or intending to acquire any interest whatsoever in the Demised Premises that this Lease has not been assigned, amended, changed, or modified, is in full force and
effect and that the minimum annual and additional rent have been duly and fully paid not beyond the respective due dates immediately preceding the date of the request for such statement and shall constitute as to any persons entitled to rely on such
statements a waiver of any defaults by Landlord or defenses or offsets against the enforcement of this Lease by Landlord which may exist prior to the date of the written request. Landlord at its option, may treat such failure as a deliberate event
of default. 
  

					
		  	Endo Pharmaceuticals Inc.	  	Page 28
		  	Confidential	  	

 29. SUBORDINATION AND ATTORNMENT. 
 Tenant agrees: 
 a. That,
except as hereinafter provided, this Lease is, and all of Tenant’s rights hereunder are and shall always be, subject and subordinate to any first mortgage, leases of Landlord’s property (in sale-leaseback) pursuant to which Landlord has or
shall retain the right of possession of the Demised Premises or security instruments (collectively called “Mortgage”) that now exist, or may hereafter be placed upon the Demised Premises or any part thereof and to all advances made or to
be made thereunder and to the interest thereon and all renewals, replacements, modifications, consolidations, or extensions thereof; and 
 b. That if the holder of any such Mortgage (“Mortgagee”) or if the purchaser at any foreclosure sale or at any sale under a power of sale contained in any Mortgage shall at its sole option so request, Tenant
will attorn to, and recognize such mortgagee or purchaser, as the case may be, as Landlord under this Lease for the balance then remaining of the term of this Lease, subject to all terms of this Lease; and 
 c. That the aforesaid provisions shall be self-operative and no further instrument or document shall be necessary unless required by any
such mortgagee or purchaser. Notwithstanding anything to the contrary set forth above, mortgagee may at any time subordinate its mortgage to this Lease, without Tenant’s consent, by notice in writing to Tenant, and thereupon this Lease shall be
deemed prior to such mortgage without regard to their respective dates of execution, delivery and/or recording and in that event such mortgagee shall have the same rights with respect to this Lease as though this Lease had been executed and a
memorandum thereof recorded prior to the execution, delivery and recording of the mortgage and as though this Lease had been assigned to such mortgagee. Should Landlord or any mortgagee or purchaser desire confirmation of either such subordination
or such attornment, as the case may be, Tenant, upon written request, and from time to time, will execute and deliver without change and in form satisfactory to Landlord and the mortgagee or the purchaser all instruments and/or documents that may be
requested to acknowledge such subordination and/or agreement to attorn, in recordable form. 
 30. QUIET ENJOYMENT.

 Tenant, on paying the rent reserved, and performing all the covenants and conditions hereof, shall at all times during the Demised Term,
peaceably and quietly have, hold and enjoy the Demised Premises; provided, however, that no eviction of the Tenant by reason of the foreclosure of any mortgage now or hereafter on the Demised Premises shall be construed as a breach of this 

  

					
		  	Endo Pharmaceuticals Inc.	  	Page 29
		  	Confidential	  	

 
covenant, nor shall any action by reason thereof be brought against the Landlord; and provided further, that no eviction of the Tenant for any reason
whatever, after the Landlord shall have conveyed the fee of the Demised Premises, shall be construed as a breach of this covenant by the present Landlord, and no action therefore shall be brought against the present Landlord. 
 31. NOTICES. 
 All
notices required to be given shall be by certified mail, return receipt requested, or by a recognized overnight delivery service. 
  

			
	TO LANDLORD:	  	 Painters’ Crossing Three Associates, L.P.
 112
Chesley Drive, Suite 200
 Media, PA 19063-1762

		
		  	ATTN: Legal Department
		
	TO TENANT:	  	 Endo Pharmaceuticals Inc.
 100 Endo Boulevard

Painters’ Crossing Office Campus
 Chadds Ford, PA
19317

		
		  	ATTN: General Counsel

 Such addresses may be changed from time to time by either party by serving notices as provided.
Notice shall be deemed given two (2) days after postmarked in the case of the U. S. Mail or upon delivery or refusal of delivery in the case of a recognized overnight delivery service. 
 32. LEASE CONTAINS ALL AGREEMENTS. 
 It is expressly understood and agreed by and between the parties hereto that this Lease sets forth all the promises, agreements and conditions or understandings between Landlord or his Agent and Tenant relative to the
Demised Premises, and that there are no promises, agreements, conditions or understandings, either oral or written, between them other than are herein set forth. It is further understood and agreed that, except as herein otherwise provided, no
subsequent alteration, amendment, change or addition to this Lease shall be binding upon Landlord or Tenant unless reduced to writing and signed by them. 
  

					
		  	Endo Pharmaceuticals Inc.	  	Page 30
		  	Confidential	  	

 33. HEIRS AND ASSIGNEES. 
 All rights and liabilities herein given to, or imposed upon, the respective parties hereto shall extend to and bind the several and respective heirs,
executors, administrators, successors and assigns of said parties; and if there shall be more than one Tenant, they shall all be bound jointly and severally by the terms, covenants and agreements herein, and the word “Tenant” shall be
deemed and taken to mean each and every person or party mentioned as a Tenant herein, be the same one or more; and if there shall be more than one Tenant, any notice required or permitted by the terms of this Lease may be given by or to any one
thereof, and shall have the same force and effect as if given by or to all thereof. The words “his” and “him” wherever stated herein, shall be deemed to refer to the “Landlord” or “Tenant” whether such
Landlord or Tenant be singular or plural and irrespective of gender. No rights, however, shall inure to the benefit of any assignee of Tenant unless the assignment to such assignee has been approved by Landlord in writing as aforesaid. 

34. LATE PAYMENT. 
 In the event that any payment of Annual Base Rent or additional rent or any other charge required to be paid by Tenant under the provisions of this Lease, shall not be paid within five (5) days of the due date, Tenant shall pay to
Landlord a late charge of five percent (5%) of such past due payment; and such late charge shall be deemed “rent” for all purposes under this Lease. 
 35. HEADINGS NO PART OF LEASE. 
 Any headings preceding the text of the several
paragraphs and subparagraphs hereof are inserted solely for convenience of reference and shall not constitute a part of this Lease nor shall they affect its meaning, construction or effect. 
 36. SEVERABILITY. 
 If a
provision of this Lease Agreement is held invalid, it is hereby agreed that all valid provisions that are severable from the invalid provision remain in effect. If a provision in this Lease Agreement is held invalid in one or more of its
applications, the provision remains in effect in all valid applications. 
  

					
		  	Endo Pharmaceuticals Inc.	  	Page 31
		  	Confidential	  	

 37. LIABILITY OF LANDLORD. 
 The liability of Landlord hereunder and all of its partners, if any, whether general or limited, shall be limited to Landlord’s estate or other title
or interest in the building of which the Demised Premises is a part. It is further covenanted and agreed by the parties hereto that in no case and under no circumstances shall the Landlord be liable for any consequential damage. 
 38. RECORDING OF LEASE.  
 Tenant shall not record this Lease. If Tenant violates this covenant, Tenant hereby irrevocably authorizes, empowers and designates Landlord as its lawful attorney for the purpose of having said Lease marked satisfied of record. 

39. TERMINATION OF LEASE. 
 It is hereby mutually agreed that either party hereto may terminate this Lease at the end of the Demised Term by giving to the other party written notice thereof at least three hundred sixty-five (365) days prior thereto, but in
default of such notice, this Lease shall continue upon the same terms and conditions in force immediately prior to the expiration of the Demised Term hereof as are herein contained except for Basic Rent which shall be adjusted to reflect the then
current market rates for space comparable to the Demised Premises as determined by Landlord based upon other of Landlord’s rental properties, for a further period of one (1) year and so on from year to year unless or until termination by
either party hereto, giving the other one hundred eighty (180) days written notice for removal previous to expiration of the then current term; PROVIDED, however, that should this Lease be continued for a further period under the terms
herein-above mentioned, any allowances given Tenant on the Basic Rent during the original term shall not extend beyond such original term. In the event that Tenant shall give notice, as stipulated in this Lease, of termination of this Lease at the
end of the Demised Term, or any renewal or extension thereof, and shall fail or refuse so to vacate the same on or before the date of termination of the Lease, then it is expressly agreed that Landlord shall have the right at any time thereafter to
give seven (7) days written notice to quit; whereupon the Tenant expressly agrees to vacate said premises at the expiration of the seven (7) day period: 
 (a) Should Tenant wrongfully continue to occupy the Demised Premises after expiration of the term of this Lease or any renewal or renewals
thereof, or after a forfeiture incurred, such tenancy shall (without limitation on any of Landlord’s rights or remedies therefor) be one at sufferance from month to month at a minimum monthly rent equal to one and one-half times the Base Rent
plus additional rent payable for the last month of the term of this Lease prior to the holdover. 
  

					
		  	Endo Pharmaceuticals Inc.	  	Page 32
		  	Confidential	  	

 All powers granted to Landlord by this lease may be exercised and all obligations imposed upon Tenant by
this Lease shall be performed by Tenant as well during any extension of the Demised Term of this Lease as during the Demised Term itself. 
 40. LANDLORD’S ENVIRONMENTAL CLAUSE. 
 (a) Tenant shall not (either with or without
negligence) cause or permit the escape, disposal or release of any biologically or chemically active or other hazardous substances or materials. Tenant shall not allow the storage or use of such substances or materials in any manner not sanctioned
by law or by the highest standards prevailing in the industry for the storage and use of such substances except to use in the ordinary course of Tenant’s business, and then only after written notice is given to Landlord of the identity of such
substances or materials. Without limitation, hazardous substances and materials shall include those described in the Comprehensive Environmental Response, Compensation and Liability Act of 1980, as amended, 42 U.S.C. Section 9601 et seq., any
applicable state or local laws and the regulations adopted under these acts. If any lender or governmental agency shall ever require testing to ascertain whether or not there has been any release of hazardous materials, then the reasonable costs
thereof shall be reimbursed by Tenant to Landlord upon demand as additional charges if such requirement applies to the Premises. In addition, Tenant shall execute affidavits, representations and the like from time to time at Landlord’s request
concerning Tenant’s best knowledge and belief regarding the presence of hazardous substances or materials on the Premises. In all events, Tenant shall indemnify Landlord in the manner elsewhere provided in this lease from any release of
hazardous materials on the Premises occurring while Tenant is in possession, or elsewhere if caused by Tenant or persons acting under Tenant. The within covenants shall survive the expiration or earlier termination of the lease term. 
 (b) Tenant shall conduct all of its operations at the Premises in compliance with all federal, state and local statutes (including, but
not limited to the Comprehensive Environmental Response, Compensation, and Liability Act, 42 U.S.C. Section 9601 et. seq, as amended by the Superfund Amendments and Reauthorization Act of 1986, Pub. L. No. 99-499, 100 Stat. 1613 (October
17, 1986) (“CERCLA”); the Resources Conservation and Recovery Act, 42 U.S.C. Section 6901 et. seq. (“RCRA”); the Pennsylvania Solid Waste Management Act, 35 Pa.C.S. Section 6018.101 et. seq.; the Pennsylvania Clean

  

					
		  	Endo Pharmaceuticals Inc.	  	Page 33
		  	Confidential	  	

 
Streams Law, 35 Pa.C.S. Section 691.1 et. seq.; and the Pennsylvania Hazardous Sites Cleanup Act, Act 108 of 1988, 35 Pa.C.S. Section 6020.101 et.
seq. (“Pennsylvania Superfund”), the Clean Air Act, 42 U.S.C. Section 7401 et. seq., as amended by the Clean Air Act Amendments of 1990, the Clean Water Act, 33 U.S.C. Section 1251 et. seq., and all applicable federal, state and
local statutes related to the environment now or hereafter enacted and any additions and amendments thereto and regulations enacted thereunder, ordinances, regulations, orders and requirements of common law, regarding, but not limited to,
(i) discharges to the air, soil, surface or groundwater; and (ii) handling, utilizing, storage, treatment or disposal of any hazardous substances or toxic substances as defined therein (“Environmental Statutes”). Tenant shall
obtain all permits, licenses or approvals and shall make all notifications and registrations required by Environmental Statutes and shall submit to Landlord, upon request, for inspecting and copying all documents, permits, licenses, approvals,
manifests and records required to be submitted and/or maintained by the provisions of the Environmental Statutes. Tenant shall also provide promptly to Landlord copies of any correspondence, notice of violation, summons, order, complaint or other
document received by Tenant pertaining to compliance with Environmental Statutes. 
 (c) Tenant shall not install at the
Premises any temporary or permanent tanks for the storage of any liquid or gas above or below ground except as in compliance with the other provisions of this section and after obtaining written permission to do so from Landlord. 
 (d) If, because of the manner in which Tenant operates its business, the Landlord, Landlord’s mortgage lender or a governmental
agency shall require testing by an environmental testing entity of its choice, to ascertain whether there has been a release of Hazardous Materials by Tenant, its agents, servants, employees or business invitees, in or around the Demised Premises,
the reasonable costs of such testing shall be reimbursed by Tenant to Landlord as additional rent. Tenant shall execute affidavits or representations, at Landlord’s request, stating that, to the best of Tenant’s knowledge and belief, since
the time that Tenant took possession of the Demised Premises, there have been no and there presently are no Hazardous Materials present in the Demised Premises. 
 (e) Tenant hereby agrees to indemnify Landlord and to hold Landlord harmless of, from and against any and all expense, loss, cost, fines,
penalties, loss of value or liability suffered by Landlord by reason of Tenant’s breach of any of the provisions of this section. 
 (f) The provisions of this section shall survive the termination of Tenant’s tenancy or of this Lease. 
  

					
		  	Endo Pharmaceuticals Inc.	  	Page 34
		  	Confidential	  	

 41. JURISDICTION AND LAW. 
 Tenant hereby subjects itself to the jurisdiction of the Court of Common Pleas of Delaware County, Pennsylvania. The laws of the Commonwealth of
Pennsylvania shall be applicable to this lease and any interpretations thereof. 
 42. TIME IS OF THE ESSENCE.

 Time is of the essence in performing the covenants contained herein. 
 43. EXHIBITS. Attached hereto and made a part hereof are the exhibits to the Lease as follows: 
  

	 	A.	Site Plan 

  

	 	B.	Estimate of First Year’s Operating Expenses 

  

	 	C.	Building Plans 

  

	 	D.	Schedule of Construction Specifications and Finishes 

  

	 	E.	Janitorial Specifications 

  

	 	F.	Rules and Regulations 

  

	 	G.	HVAC Maintenance Contract 

  

					
		  	Endo Pharmaceuticals Inc.	  	Page 35
		  	Confidential	  	

 IN WITNESS WHEREOF, the Landlord and Tenant have duly executed this Lease as of the day and year first
above written. 
 SEALED AND DELIVERED IN 
 THE
PRESENCE OF: 
  

									
		 		 	LANDLORD:
			
		 		 	 PAINTERS’ CROSSING THREE
 ASSOCIATES, L.P.

					
		 		 		 	By:	 	Henderson P.O.C. Three, LLC, General
		 		 		 		 	Partner
					
	WITNESS:	 	/s/ Patrick Tomlinson	 		 	BY:	 	/s/ Wilbur C. Henderson
		 	Patrick Tomlinson	 		 		 	Wilbur C. Henderson, Manager
			
		 		 	TENANT:
			
		 		 	ENDO PHARMACEUTICALS INC.
					
	ATTEST:	 	/s/ Caroline B. Manogue	 		 	BY:	 	/s/ Colleen Pero
	Name:	 	Caroline B. Manogue	 		 	Name:	 	Colleen Pero
	Title:	 	 Executive Vice President,
 Chief Legal Officer
and
 Secretary
	 		 	Title:	 	 Senior Vice President of
 Corporate
Services

  

					
		  	Endo Pharmaceuticals Inc.	  	Page 36
		  	ConfidentialXTO Amended and Restated 2004 Stock Incentive Plan

 EXHIBIT 10.10 
 XTO ENERGY INC. 
 AMENDED AND RESTATED 2004 STOCK INCENTIVE PLAN 
 (As amended and restated through November 21, 2006) 
 1. Purpose 
 The purpose of the XTO Energy Inc. Amended and Restated 2004 Stock Incentive Plan(the “Plan”) is to
provide designated employees of XTO Energy Inc. and its subsidiaries and affiliates (collectively the “Company”) and non-employee members of the Board of Directors of the Company with the opportunity to receive equity incentive
compensation. The Company believes that the Plan will (i) help closely align the interests of Plan participants with the stockholders to generate a strong incentive to contribute to the Company’s future success and prosperity, thus
enhancing the value of the Company for the benefit of its stockholders; (ii) provide participants with a proprietary ownership interest in the Company commensurate with Company performance, as reflected in increased stockholder value;
(iii) maintain competitive compensation levels, thereby attracting and retaining highly competent and talented employees and directors; and (iv) provide an incentive to employees and directors for continued service with the Company. The
Plan has been amended and restated effective November 21, 2006. 
 2. Definitions 
 Whenever used in this Plan, the following terms will have the respective meanings set forth below: 
 (a) “Award” means an Option, Stock Appreciation Right, Stock Unit, Stock Award, Bonus Shares, Dividend Equivalent or Other Stock-Based
Award granted under the Plan. 
 (b) “Award Agreement” means the written instrument that sets forth the terms and conditions
of an Award, including all amendments thereto. 
 (c) “Board” means the Company’s Board of Directors. 
 (d) “Bonus Shares” means a grant of shares of Stock described in Section 11. 
 (e) “Change in Control” shall be deemed to have occurred if: 
 (i) “Continuing Directors” no longer constitute a majority of the Board; the term “Continuing Director” means any
individual who is a member of the Board on the Effective Date or was nominated for election as a director by, or whose nomination as a director was approved by, the Board with the affirmative vote of a majority of the Continuing Directors;

 (ii) any person or group of persons (as defined in Rule 13d-5 under the Exchange Act)
together with such person’s or its affiliates, becomes the beneficial owner, directly or indirectly, of 25% or more of the voting power of the Company’s then outstanding securities entitled generally to vote for the election of the
Company’s directors; 
 (iii) in the case of a merger or consolidation to which the Company is a party, the stockholders
of the Company immediately prior to the effective date of such merger or consolidation have beneficial ownership (as defined in Rule 13d-3 under the Exchange Act) of less than 50% of the combined voting power to vote for the election of directors of
the surviving corporation or other entity following the effective date of such merger or consolidation; or 
 (iv) the sale of
all or substantially all of the assets of the Company or the liquidation or dissolution of the Company occurs. 
 (f) “Code”
means the Internal Revenue Code of 1986, as amended. 
 (g) “Committee” means (i) with respect to Awards to Employees,
the Compensation Committee of the Board, a subcommittee thereof, or another committee appointed by the Board to administer the Plan, or its delegate, and (ii) with respect to Awards made to Non-Employee Directors, the Corporate Governance and
Nominating Committee of the Board, a subcommittee thereof, or another committee appointed by the Board to administer the Plan with respect to Non-Employee Directors. 
 (h) “Company” means XTO Energy Inc. and its subsidiaries and affiliates. 
 (i)
“Dividend Equivalent” means an Award described in Section 12. 
 (j) “Effective Date” of the Plan
means the date the Plan was most recently amended and restated by the Board. 
 (k) “Employee” means an employee of the
Company (including an officer or director who is also an employee). 
 (l) “Exchange Act” means the Securities Exchange Act
of 1934, as amended. 
 (m) “Exercise Price” means the per share price at which shares of Stock may be purchased under an
Option, as designated by the Committee. 
 (n) “Fair Market Value” of Stock means, unless the Committee determines otherwise
with respect to a particular Award, the closing market price on the Grant Date of the Award or the date of another specified event, or on the next business day, if such date is not a business day, or if no trading occurred on such date, then on the
first day preceding such date on which trading occurred, of a share of Stock traded on the New 

  

 2 

 
York Stock Exchange, or any other public securities market selected by the Committee; provided, however, that, if shares of Stock shall not have been
traded on the New York Stock Exchange or other public securities market for more than 10 days immediately preceding such date or if deemed appropriate by the Committee for any other reason, the Fair Market Value of shares of Stock shall be as
determined by the Committee in such other manner as it may deem appropriate. 
 (o) “Grant Date” means the date on which the
Committee takes action or is deemed to take action to grant an Award. 
 (p) “Incentive Stock Option” means an Option that
is intended to meet the requirements of an incentive stock option under Section 422 of the Code. 
 (q) “Non-Employee
Director” means a member of the Board who is not an employee of the Company and includes advisory directors who are not employees of the Company. 
 (r) “Nonqualified Stock Option” means an Option that is not intended to meet the requirements of an incentive stock option under Section 422 of the Code. 
 (s) “Option” means an Award to purchase shares of Stock described in Section 7. 
 (t) “Other Stock-Based Award” means any Award based on, measured by or payable in Stock (other than an Award described in
Section 7, 8, 9, 10, 11, or 12 of the Plan) described in Section 13. 
 (u) “Participant” means an Employee or
Non-Employee Director designated by the Committee to participate in the Plan. 
 (v) “Plan” means this XTO Energy Inc.
Amended and Restated 2004 Stock Incentive Plan, as in effect from time to time. 
 (w) “Senior Executive” means the
Chairman, the Chief Executive Officer, the President, the Senior Executive Vice President and Chief of Staff and any Executive Vice President of the Company. 
 (x) “Stock” means the common stock of the Company or any successor security. 
 (y)
“Stock Appreciation Right” means an Award described in Section 8. 
 (z) “Stock Award” means an Award
of Stock described in Section 10 and may be in the form of performance shares that vest based on performance or restricted shares that vest over time. 
  

 3 

 (aa) “Stock Unit” means an Award of a unit representing a share of Stock described in
Section 9 and may be in the form of phantom or restricted units that vest based on performance or that vest over time. 
 3. Administration

 (a) Committee. The Plan shall be administered and interpreted by the Compensation Committee with respect to Awards to Employees.
The Plan shall be administered and interpreted by the Corporate Governance and Nominating Committee with respect to Awards to Non-Employee Directors. The Committee, as applicable, that has authority with respect to a specific Award shall be referred
to as the “Committee” with respect to that Award. 
 (b) Committee Authority. The Committee shall have the full power and
express authority to (i) administer and interpret the Plan, (ii) make factual determinations, (iii) adopt or amend such rules, regulations, agreements and instruments for implementing the Plan and for the conduct of its business,
(iv) determine the Participants to whom Awards shall be made under the Plan, (v) determine the type, size and terms and other conditions of the Awards to be made to each such Participant, (vi) determine the time when the Awards will
be made and the duration of any applicable exercise or restriction period, including the criteria for exercisability and the acceleration of exercisability, (vii) amend the terms and conditions of any previously issued Award, subject to the
material impairment provisions of Section 21(a) and the provisions of Section 21(b), and (viii) deal with any other matters arising under the Plan. 
 (c) Committee Determinations. The Committee’s interpretations of the Plan and all determinations made by the Committee pursuant to the powers vested in it hereunder shall be final, conclusive, and binding
on all persons having any interest in the Plan or in any Awards granted hereunder. All powers of the Committee shall be executed in its sole discretion, in the best interest of the Company, not as a fiduciary, in keeping with the objectives of the
Plan, and need not be uniform as to similarly situated Participants. 
 (d) Delegation of Committee Authority. The Committee may
delegate any or all of its power and authority under this Section 3 relating to the selection of Employees for participation, the grant of Awards to Employees, and other actions under the Plan relating to Employees, to the extent permitted by
applicable law and stock exchange requirements. Such delegation shall be made only to a Senior Executive or a committee of two or more Senior Executives. In the case of any such delegation, reference in the Plan to the Committee shall be deemed to
include the Senior Executive or committee to which authority has been delegated with respect to Employees; provided, however, that the Committee may impose any term or limitation upon the exercise of such delegated authority not inconsistent
with the Plan. The Committee may not make such delegation with respect to any Award granted to a Senior Executive. The Committee may delegate to officers or other Employees, subject to such terms as the Committee shall determine, the duty to perform
ministerial functions under the Plan. 
  

 4 

 (e) Limitation of Liability. Each member of the Committee shall be entitled to, in good faith,
rely or act upon any report or other information furnished to him or her by any officer of the Company or other Employee, the Company’s independent registered public accounting firm, or any executive compensation consultant, legal counsel, or
other professional retained by the Company to assist in the administration of the Plan. No member of the Committee, nor any officer or other Employee acting on behalf of the Committee, shall be personally liable for any action, determination, or
interpretation taken or made in good faith with respect to the Plan or any Award, and all members of the Committee and any Senior Officer or other Employee acting on behalf of the Committee shall, to the extent permitted by law, be fully indemnified
and protected by the Company with respect to any such action, determination, or interpretation. 
 4. Awards 
 (a) Types of Awards. Awards under the Plan may consist of Options described in Section 7, Stock Appreciation Rights described in
Section 8, Stock Units described in Section 9, Stock Awards described in Section 10, Bonus Shares described in Section 11, Dividend Equivalents described in Section 12 and Other Stock-Based Awards described in
Section 13. All Awards shall be subject to such terms and conditions as the Committee may determine and as are specified in writing by the Committee in the Award Agreement. 
 (b) Award Agreements. All Awards shall be evidenced by Award Agreements. All Awards shall be conditional upon the Participant’s
acknowledgement, in writing or by acceptance of the Award, that all decisions and determinations of the Committee shall be final, conclusive, and binding on the Participant, his or her beneficiaries and any other person having or claiming an
interest under such Award. 
 (c) Minimum Vesting Provisions. All Awards can become exercisable or have restrictions that lapse based
on the passage of time or achievement of designated performance criteria. Awards, other than Bonus Shares, which are not subject to achievement of performance-based criteria, will have a minimum vesting period of ratably over three years, subject to
acceleration as described herein. 
 5. Shares Subject to the Plan 
 (a) Shares Authorized. The total aggregate number of shares of Stock that may be issued under the Plan is 33,750,000 shares, subject to adjustment. All shares of Stock that may be issued under the Plan may be
granted in the form of Nonqualified Stock Options or Incentive Stock Options. 
 (b) Limit on “Full-Value” Awards. Within
the aggregate limit described in subsection (a), the maximum number of shares of Stock that may be issued under the Plan in connection with “full-value” Awards, meaning Awards other than Options, SARs settled in cash, or Awards for which
the Participant pays at least the Fair Market Value 

  

 5 

 
for the shares of Stock subject thereto, determined on the Grant Date of the Award (in cash or other consideration designated as acceptable by the
Committee), is 2,500,000 shares, subject to adjustment. Notwithstanding the foregoing, in the event the number of shares available for full-value Awards has been used, the Company may grant additional full-value Awards from the remaining shares
available for grant under subsection (a) with each such full-value Award counting as three shares against the remaining shares available under subsection (a). 
 (c) Source of Shares. Shares issued under the Plan may be authorized but unissued shares of Stock, treasury shares, or shares purchased by the Company on the open market for purposes of the Plan. 
 (d) Share Counting. For administrative purposes, when the Committee makes an Award that may be payable in Stock, the Committee shall reserve a
number of shares equal to the maximum number of shares that may be issued under the Award. The total number of shares subject to an option or SAR settled in Stock shall be counted against the share limits described in subsections (a) and
(b) above. Any shares of Stock related to Awards which (i) terminate by expiration, forfeiture, cancellation, or otherwise without the issuance of such shares, (ii) are settled in cash in lieu of the issuance of shares, or
(iii) are exchanged prior to the issuance of shares for Awards not settled in shares, shall not reduce or otherwise count against the share limits described in subsections (a) and (b) above. Until May 16, 2006, if the Participant
tenders previously-acquired shares of Stock in satisfaction of applicable withholding tax obligations or if any shares of Stock covered by an Award are not delivered to the Participant because such shares are withheld to satisfy applicable
withholding tax obligations, such shares shall again be available for further Awards under the Plan. From and after May 16, 2006, shares withheld or tendered to pay withholding tax obligations will no longer become available again for Awards
under the Plan. Awards paid in cash shall not count against the share limits described in subsections (a) and (b) above. 
 (e)
Individual Limits. All Awards under the Plan, other than Dividend Equivalents, shall be expressed in shares of Stock or share equivalents, or valued by reference to shares of Stock. The maximum aggregate number of shares of Stock with respect
to which Options and SARs settled in cash may be granted under the Plan to any individual during any calendar year shall be 3,333,333 shares, subject to adjustment. The maximum aggregate number of shares of Stock with respect to which all Awards,
other than Options, SARs settled in cash, and Dividend Equivalents, may be granted under the Plan to any individual during any calendar year shall be 666,666 shares, subject to adjustment. A Participant may not accrue Dividend Equivalents during any
calendar year in excess of the amount of dividends actually declared with respect to 3,333,333 shares, subject to adjustment. The maximum aggregate number of shares of Stock with respect to which Awards may be granted to any individual Non-Employee
Director during any calendar year shall be 20,000 shares, subject to adjustment. The individual limits of this subsection (e) shall apply without regard to whether the Awards are to be paid in Stock or cash. All cash payments (other than with
respect to Dividend Equivalents) shall equal the Fair Market Value of the shares of Stock to which the cash payments relate. 
  

 6 

 (f) Adjustments. Subject to Section 19, if there is any change in the number or kind of
shares of Stock outstanding (i) by reason of a stock dividend, spinoff, recapitalization, stock split, or combination or exchange of shares, (ii) by reason of a merger, reorganization, or consolidation, (iii) by reason of a
reclassification or change in par value, or (iv) by reason of any other extraordinary or unusual event affecting the outstanding Stock as a class without the Company’s receipt of consideration, or if the value of outstanding shares of
Stock is reduced as a result of a spinoff or the Company’s payment of an extraordinary cash dividend or distribution, or dividend or distribution consisting of any assets of the Company other than cash, the maximum number and kind of shares of
Stock available for issuance under the Plan, the maximum number and kind of shares of Stock available for issuance of “full-value” Awards, the maximum number and kind of shares of Stock for which any individual may receive Awards or
Dividend Equivalents in any year, the number and kind of shares of Stock covered by outstanding Awards, and the price per share or the applicable market value or performance target of such Awards shall be appropriately adjusted by the Committee to
reflect any increase or decrease in the number of, or change in the kind or value of, issued shares of Stock to preclude, to the extent practicable, the enlargement or dilution of rights under such Awards; provided, however, that any
fractional shares resulting from such adjustment shall be eliminated. 
 6. Eligibility for Participation 
 (a) Eligible Persons. Employees and Non-Employee Directors shall be eligible to participate in the Plan. 
 (b) Selection of Participants. The Committee shall select the Employees and Non-Employee Directors to receive Awards. 
 7. Options 
 (a) General Requirements. The
Committee may grant Options to an Employee or Non-Employee Director upon such terms and conditions as the Committee may determine under this Section 7. The Committee shall determine the number of shares of Stock that will be subject to each
grant of Options. The Committee may not grant Dividend Equivalents with respect to Options. 
 (b) Type of Option, Price, and Term.

 (i) The Committee may grant Incentive Stock Options or Nonqualified Stock Options or any combination of the two, all in
accordance with the terms and conditions set forth herein. Incentive Stock Options may be granted only to Employees of the Company or its parents or subsidiaries, as defined in section 424 of the Code. Nonqualified Stock Options may be granted to
Employees or Non-Employee Directors. 
  

 7 

 (ii) The Exercise Price of an Option shall be determined by the Committee and shall be
equal to or greater than the Fair Market Value of a share of Stock on the Grant Date; provided, however, that an Incentive Stock Option may not be granted to an Employee who, at the time of grant, owns stock possessing more than 10 percent of
the total combined voting power of all classes of stock of the Company or any parent or subsidiary, as defined in section 424 of the Code, unless the Exercise Price is not less than 110% of the Fair Market Value of the Stock on the Grant Date.

 (iii) The Committee shall determine the term of each Option, which shall not exceed seven years from the Grant Date.
However, an Incentive Stock Option that is granted to an Employee who, at the time of grant, owns stock possessing more than 10 percent of the total combined voting power of all classes of stock of the Company or any parent or subsidiary, as defined
in section 424 of the Code, may not have a term that exceeds five years from the Grant Date. 
 (c) Exercisability of Options. Options
shall become exercisable in accordance with such terms and conditions as may be determined by the Committee. The Committee may accelerate the exercisability of any or all outstanding Options at any time for any reason. 
 (d) Exercise of Options. A Participant may exercise an Option that has become exercisable, in whole or in part, by delivering a notice of exercise
to the Company. The Participant shall pay the Exercise Price for the Option (i) in cash, (ii) by delivering shares of Stock owned by the Participant and having a Fair Market Value on the date of exercise equal to the Exercise Price or by
attestation to ownership of shares of Stock having an aggregate Fair Market Value on the date of exercise equal to the Exercise Price, (iii) by payment through broker-assisted cashless exercise arrangements, or (iv) by such other method as
the Committee may approve. Shares of Stock used to exercise an Option shall have been held by the Participant for the requisite period of time, if any, to avoid adverse accounting consequences to the Company with respect to the Option. Payment for
shares of Stock to be issued pursuant to the exercise of an Option, and any required withholding taxes, must be received by the Company by the time specified by the Committee depending on the type of payment being made, but in all cases prior to the
issuance of the shares. 
 (e) Limits on Incentive Stock Options. Each Award Agreement with respect to an Incentive Stock Option shall
provide that, if the aggregate Fair Market Value of the Stock on the Grant Date of the Incentive Stock Option which first becomes exercisable by a Participant during any calendar year, under the Plan or any other plan of the Company or a parent or
subsidiary, as defined in section 424 of the Code, exceeds $100,000, then the Option, as to the excess, shall be treated as a Nonqualified Stock Option. 
 8. Stock Appreciation Rights 
 (a) General Requirements. The Committee may grant Stock Appreciation Rights
(“SARs”) to an Employee or Non-Employee Director upon such terms and conditions as 

  

 8 

 
the Committee may determine under this Section 8. An SAR shall confer on the Participant to whom it is granted a right to receive, upon exercise
thereof, in cash, Stock or a combination of the two, the excess of (i) the Fair Market Value of a share of Stock on the date of exercise, over (ii) the grant price of the SAR as determined by the Committee as of the Grant Date of the SAR,
which shall be equal to or greater than the Fair Market Value of a share of Stock on the date the SAR is granted. 
 (b) Terms of
SARs. The Committee shall determine the time or times when an SAR may be exercised in whole or in part, the method of exercise, method of settlement, whether cash, Stock, or a combination of the two shall be payable to the Participant upon
exercise, the method by which Stock will be delivered or deemed to be delivered to Participants, whether an SAR shall be in tandem with any other Award, and any other terms and conditions of an SAR. The Committee may not grant Dividend Equivalents
with respect to an SAR. The term of an SAR may not exceed seven years from the Grant Date. 
 9. Stock Units 
 (a) General Requirements. The Committee may grant Stock Units to an Employee or Non-Employee Director upon such terms and conditions as the
Committee may determine under this Section 9. Each Stock Unit shall represent the right of the Participant to receive a share of Stock or an amount of cash based upon the value of a share of Stock. All Stock Units shall be recorded in memo
bookkeeping accounts for purposes of the Plan. 
 (b) Terms of Stock Units. The Committee may grant Stock Units that are payable on
terms and conditions determined by the Committee. Stock Units may be paid at the end of a specified vesting or performance period. The Committee shall determine the number of Stock Units to be granted and the requirements applicable to such Stock
Units. The Committee may grant Dividend Equivalents with respect to Stock Units. 
 (c) Payment with Respect to Stock Units. Payment
with respect to Stock Units shall be made in cash, Stock, or a combination of the two, as determined by the Committee. 
 10. Stock Awards 

(a) General Requirements. The Committee may issue shares of Stock to an Employee or Non-Employee Director under a Stock Award upon such terms
and conditions as the Committee may determine under this Section 10, subject to restrictions or no restrictions, as determined by the Committee. Shares of Stock issued pursuant to Stock Awards may be issued for cash consideration or for no cash
consideration. The Committee may establish conditions under which restrictions on Stock Awards shall lapse over a period of time or according to such other criteria, including performance criteria, as the Committee may determine. The Committee shall
determine the number of shares of Stock to be issued pursuant to a Stock Award. 
  

 9 

 (b) Restrictions on Transfer. While shares of Stock subject to a Stock Award are subject to
restrictions on transferability, a Participant may not sell, assign, transfer, pledge, or otherwise dispose of such shares except upon death as described in Section 17(a). Each certificate for shares of Stock subject to a Stock Award shall
contain a legend giving appropriate notice of the restrictions on the shares. The Participant shall be entitled to have the legend removed when all restrictions on such shares have lapsed. The Company may retain possession of any certificates for
shares of Stock subject to a Stock Award until all restrictions on such shares have lapsed. If non-certificated shares representing the Stock subject to a Stock Award are registered in the name of the Participant, such shares shall be maintained in
a separate restricted share account subject to terms, conditions and restrictions of like effect. 
 (c) Right to Vote and to Receive
Dividends. Once shares of Stock subject to a Stock Award have been registered in the name of a Participant, the Participant shall have the right to vote such shares of Stock and to receive any dividends or other distributions paid on such shares
during the restriction period. Dividends paid on Stock Awards are not considered Dividend Equivalents. 
 (d) Purchase of Stock by the
Company. On the date all restrictions on shares of Stock subject to a Stock Award have lapsed, subject to the approval by the Committee, the Participant may request the Company to purchase some or all of the Participant’s shares subject to
the Stock Award at the Fair Market Value on the date the restrictions have lapsed. Within seven business days after receipt of the Participant’s request, the Committee shall inform the Participant of its decision whether to approve the purchase
of such shares of Stock. 
 11. Bonus Shares and Awards in Lieu of Other Cash Obligations 
 The Committee may grant shares of Stock as a bonus, or grant shares of Stock or other Awards in lieu of Company obligations to pay cash or grant awards
under other plans or compensatory arrangements. Stock or Awards granted hereunder shall be subject to such other terms as shall be determined by the Committee. 
 12. Dividend Equivalents. 
 (a) General Requirements. When the Committee makes an Award, other than an Option or SAR,
the Committee may grant Dividend Equivalents in connection with the Award, under such terms and conditions as the Committee may determine under this Section 12. Dividend Equivalents may be accrued as a cash obligation, or may be converted to
Stock Units, and deferred Dividend Equivalents may accrue interest, all as determined by the Committee. The amount to be paid under a Dividend Equivalent shall be determined by multiplying the number of shares of Stock subject to an Award by the
per-share cash dividend, or the per-share fair market value (as determined by the Committee) of any dividend in consideration other than cash, paid by the Company on its Stock. 
  

 10 

 (b) Payment with Respect to Dividend Equivalents. Dividend Equivalents may be payable in cash,
Stock, or a combination of the two, as determined by the Committee. 
 13. Other Stock-Based Awards 
 The Committee may grant other Awards not specified in Sections 7, 8, 9, 10, 11 and 12 that are based on, measured by, or payable in Stock to Employees or
Non-Employee Directors on such terms and conditions as the Committee may determine under this Section 13. Other Stock-Based Awards may be payable in cash, Stock, or a combination of the two, as determined by the Committee. The Committee may
grant Dividend Equivalents with respect to Other Stock-Based Awards. 
 14. Qualified Performance-Based Awards 
 (a) Designation as Qualified Performance-Based Awards. The Committee may grant Employees Options, SARs, Stock Units, Stock Awards, Dividend
Equivalents, or Other Stock-Based Awards considered to be “qualified performance-based compensation” under Section 162(m) of the Code, in which case the provisions of this Section 14 shall apply to such Awards. 
 (b) Performance Goals. When Awards are made under this Section 14, the Committee shall establish in writing (i) the objective
performance goals that must be met, (ii) the period during which performance will be measured, (iii) the maximum number of shares of Stock or amount of cash that may be paid if the performance goals are met, and (iv) any other
conditions that the Committee deems appropriate and consistent with the requirements of Section 162(m) of the Code for “qualified performance-based compensation.” The performance goals shall satisfy the requirements for
“qualified performance-based compensation.” The Committee shall not have discretion to increase the amount of compensation that is payable, but may reduce the amount of compensation that is payable, pursuant to Awards identified by the
Committee as “qualified performance-based compensation.” 
 (c) Business Criteria Used for Objective Performance Goals. The
Committee shall use objectively determinable performance goals based on one or more of the following business criteria: market price of the Stock, cash flow, reserve value, net asset value, earnings, net income, operating income, cash from
operations, revenue, margin, EBITDA (earnings before interest, taxes, depreciation and amortization), EBITDAX (earnings before interest, taxes, depreciation, amortization and exploration expense), net capital employed, return on assets, stockholder
return, reserve replacement, return on equity, return on capital employed, production, assets, unit volume, sales, market share, finding and development costs, overhead costs, general and administration expense, or strategic business criteria
consisting of one or more objectives based on meeting specified goals relating to acquisitions or divestitures. The targeted level or levels of performance with respect to such goals may be established at such levels and in such terms as the
Committee may determine, including in absolute terms or per share terms, as a goal 

  

 11 

 
relative to performance in prior periods, or as a goal compared to the performance of one or more comparable companies or an index covering multiple
companies. The performance goals may relate to one or more regions or districts or may relate to the performance of the Company as a whole, individual performance, or any combination of the foregoing. Performance goals need not be uniform as among
Participants. 
 (d) Timing of Establishment of Goals. The Committee shall establish the performance goals in writing either before
the beginning of the performance period or during a period ending no later than the earlier of (i) 90 days after the beginning of the performance period or (ii) the date on which 25% of the performance period has been completed, or such
other date as may be required or permitted under applicable regulations under Section 162(m) of the Code. 
 (e) Certification of
Results. The Committee shall certify the performance results for the performance period for the Award after the performance period ends. The Committee shall determine the amount, if any, to be paid pursuant to each Award based on the achievement
of the performance goals and the satisfaction of all other terms of the Award. Certification by the Committee is not required for compensation that is attributable solely to the increase in the value of the Stock. 
 (f) Death, Disability or Other Circumstances. The Committee may provide that Awards under this Section 14 shall be payable, in whole or in
part, in the event of the Participant’s death or permanent disability, a Change in Control, or under other circumstances consistent with the applicable regulations under Section 162(m) of the Code. 
 15. Deferrals 
 The Committee may permit or require a
Participant to defer receipt of the payment of cash or the delivery of shares of Stock that would otherwise be due to the Participant in connection with any Award. Awards that are not paid currently shall be recorded as payable on the Company’s
records for the Plan. 
 16. Withholding of Taxes 
 (a) Required Withholding. All Awards shall be subject to applicable federal (including FICA), state, and local tax withholding requirements. The Company may require that the Participant or other person receiving or exercising Awards
pay to the Company the amount of any federal, state, or local taxes that the Company is required to withhold with respect to such Awards, or the Company may deduct from wages or other amounts payable by the Company the amount of any withholding
taxes due with respect to such Awards. 
 (b) Election to Withhold Shares. If the Committee so permits, a Participant may elect to
satisfy the Company’s tax withholding obligation with respect to Awards paid in Stock by having shares withheld at the time such Awards become taxable. Shares may 

  

 12 

 
not be withheld in an amount that would result in additional compensation being recorded by the Company in its financial statements. The election must be in
a form and manner prescribed by the Committee. 
 17. Transferability of Awards 
 (a) Restrictions on Transfer. Except as described in subsection (b), only the Participant is entitled to any rights under an Award during the
Participant’s lifetime, and a Participant may not transfer those rights except by will or by the laws of descent and distribution. When a Participant dies, the personal representative, beneficiary, or other person entitled to succeed to the
rights of the Participant may acquire the rights under an Award. Any such successor must furnish proof satisfactory to the Company of the successor’s entitlement to receive the rights under an Award under the Participant’s will or under
the applicable laws of descent and distribution. 
 (b) Transfer of Nonqualified Stock Options to or for Family Members.
Notwithstanding the foregoing, the Committee may provide that a Participant may transfer Nonqualified Stock Options to family members, or one or more trusts or other entities for the benefit of or owned by family members, consistent with the
applicable securities laws, according to such terms as the Committee may determine; provided, however, that the Participant receives no consideration for the transfer of the Options and the transferred Options shall continue to be subject to
the same terms and conditions as were applicable to the Options immediately before the transfer. 
 18. Death, Disability, Retirement, and Other
Termination of Employment or Service 
 Unless otherwise determined by the Committee: 
 (a) Employee Nonqualified Stock Options and Stock Appreciation Rights. 
 (i) Upon the death of an Employee, all Nonqualified Stock Options and SARs shall vest immediately on the date of death and may be
exercised by the Employee’s estate, or by a person who acquires the right to exercise such Nonqualified Stock Option or SAR by bequest or inheritance or by reason of the death of the Employee; provided, however, that such exercise occurs
within both (x) the remaining term of the Nonqualified Option or SAR and (y) one year after such death. The provisions of this Section shall apply notwithstanding that the Employee’s employment may have terminated prior to death, but
the Nonqualified Stock Options and SARs shall only be exercisable to the extent any rights exercisable on the date of termination of the Employee’s employment remained exercisable on the date of death. 
 (ii) Upon termination of an Employee’s employment by reason of retirement or permanent disability (as each is determined by the
Committee), the Employee may exercise any Nonqualified Stock Option or SAR to the extent exercisable on the date of termination of the Employee’s employment; provided, however, such exercise 

  

 13 

 
occurs within both (x) the remaining term of the Nonqualified Option or SAR and (y) one year after such termination. 
 (iii) In the event of the termination of an Employee’s employment for cause (as determined by the Committee), all Nonqualified Stock
Options and SARs shall terminate immediately upon the termination of the Employee’s employment. 
 (iv) Upon termination
of an Employee’s employment by reason other than death, retirement, permanent disability, or cause, the Employee may exercise any Nonqualified Stock Option or SAR, to the extent exercisable on the date of termination of the Employee’s
employment; provided, however, such exercise occurs within both (x) the remaining term of the Nonqualified Option or SAR and (y) 90 days after the date of termination. 
 (b) Incentive Stock Options  
 (i) Upon the death of an Employee, any Incentive Stock Option shall vest immediately on the date of death and may be exercised by the Employee’s estate or by a person who acquires the right to exercise such Incentive Stock Option by
bequest or inheritance or by reason of the death of the Employee; provided, however, that such exercise occurs within both (x) the remaining term of the Incentive Stock Option and (y) one year after the Employee’s death. The
provisions of this Section shall apply notwithstanding that the Employee’s employment may have terminated prior to death, but the Incentive Stock Options shall only be exercisable to the extent any Incentive Stock Options exercisable on the
date of termination of the Employee’s employment remained exercisable on the date of death. 
 (ii) Upon termination of
an Employee’s employment by reason of permanent disability or retirement (as each is determined by the Committee), the Employee may exercise any Incentive Stock Option, to the extent exercisable on the date of termination of the Employee’s
employment; provided, however, such exercise occurs within both (x) the remaining term of the Incentive Stock Option and (y) one year after such termination. 
 (iii) Except as provided in (b)(i) and (b)(ii) or otherwise determined by the Committee, all Incentive Stock Options shall terminate
immediately upon the termination of the Employee’s employment. 
 (iv) Notwithstanding the terms of the Award, the tax
treatment available pursuant to Section 422 of the Code upon the exercise of an Incentive Stock Option shall not be available to an Employee who exercises any Incentive Stock Option more than one year after the date of termination of employment
due to death or permanent disability or three months after the date of termination of employment due to retirement. 
  

 14 

 (c) Other Employee Awards. Upon the death of an Employee all outstanding Stock Units, Stock
Awards, Dividend Equivalents, and Other Stock-Based Awards shall vest immediately. Unless the Award provides for vesting upon permanent disability, retirement, or other termination of employment, upon any such termination of employment of an
Employee prior to vesting of Stock Units, Stock Awards, Dividend Equivalents, and Other Stock-Based Awards, all such outstanding and unvested Awards to the Participant shall be canceled, shall not vest, and shall be returned to the Company.

 (d) Non-Employee Directors. When a Non-Employee Director does not continue as a director of the Company for any reason (other than
in the event of death), the Non-Employee Director may thereafter exercise only those Options and SARs that were exercisable upon the date that the director ceased to be a director and only during the shorter of (x) the period occurring within
two years after such date or, (y) the remaining term of the Option or SAR. The provisions of Section 18(a)(i) relating to the death of an Employee shall also apply to Options and SARs granted to Non-Employee Directors. The provisions of
Section 18(c) shall also apply to all other Awards to Non-Employee Directors. 
 19. Consequences of a Change in Control 
 (a) Vesting of Awards. Upon a Change in Control, all outstanding Options and SARs shall be fully exercisable, and restrictions on outstanding Stock
Units, Stock Awards, Dividend Equivalents, and Other Stock-Based Awards shall lapse. Such acceleration or lapse shall take place as of the date of the Change in Control or such other date as the Committee may specify. 
 (b) Assumption of Awards. Upon a Change in Control where the Company is not the surviving corporation (or survives only as a subsidiary of another
corporation), all outstanding Options and SARs that are not exercised prior to the Change in Control shall be assumed by, or replaced with comparable awards by, the surviving corporation (or a parent or subsidiary of the surviving corporation), and
other Awards shall remain outstanding after the Change in Control and be converted to comparable awards of the surviving corporation (or a parent or subsidiary of the surviving corporation). Such assumption or replacement shall take place as of the
date of the Change in Control or such other date as the Committee may specify. 
 (c) Other Alternatives. Notwithstanding the
foregoing, in the event of a Change in Control, the Committee may take any of the following actions with respect to any or all outstanding Awards, without the consent of any Participant: (i) the Committee may require that Participants surrender
their outstanding Options and SARs in exchange for payment by the Company, in cash, Stock, or a combination of the two, as determined by the Committee, in an amount equal to the amount, if any, by which the then Fair Market Value of the shares of
Stock subject to the Participant’s unexercised Options and SARs exceeds the Exercise Price or grant price, and (ii) with respect to Participants holding Stock Units, Stock Awards, Dividend Equivalents, or Other Stock-Based Awards, the

  

 15 

 
Committee may determine that such Participants shall receive payment in settlement of such Stock Units, Stock Awards, Dividend Equivalents, or Other
Stock-Based Awards, in such amount and form and on such terms as may be determined by the Committee. Such surrender or settlement shall take place as of the date of the Change in Control or such other date as the Committee may specify. 

(d) Other Transactions. The Committee may provide in an Award that a sale or other transaction involving a subsidiary or other business unit of
the Company shall be considered a Change in Control for purposes of the Award, or the Committee may establish other provisions that shall be applicable in the event of a specified transaction. 
 (e) Committee. The Committee making the determinations under this Section 19 following a Change in Control must be composed of the same
members as those of the Committee immediately before the Change in Control. If the Committee members do not meet this requirement, the automatic provision of subsections (a) and (b) shall apply, and the Committee shall not have discretion
to vary them. 
 20. Requirements for Issuance of Shares 
 No shares of Stock shall be issued in connection with any Award unless and until all legal and stock exchange requirements applicable to the issuance of such shares have been complied with to the satisfaction of the
Committee. The Committee shall have the right to condition any Award made on the Participant’s undertaking in writing to comply with such restrictions on the Participant’s subsequent disposition of such shares as the Committee shall
determine, and certificates representing such shares may be legended to reflect any such restrictions. Certificates representing shares of Stock issued under the Plan shall be subject to such stop-transfer orders and other restrictions as may be
required by applicable laws, regulations and interpretations, including any requirement that a legend be placed thereon. 
 21. Amendment and Termination
of the Plan 
 (a) Amendment. The Board may amend or terminate the Plan at any time; provided, however, that the Board shall
not amend the Plan without approval of the stockholders of the Company if such amendment is material and approval is required in order to comply with the Code or applicable laws or stock exchange requirements. No amendment or termination of the Plan
shall, without the consent of the Participant, materially impair any rights or obligations under any Award previously made to the Participant, unless such right has been reserved in the Plan or the Award, or except as provided in Section 22(b).
An amendment to the Plan shall not be considered material if it curtails rather than expands the scope of the Plan. 
 (b) No Repricing
Without Stockholder Approval. Notwithstanding anything in the Plan to the contrary, the Committee may not reprice Options or SARs, nor may the Board amend the Plan to permit such repricing, unless the stockholders of the Company provide prior
approval for such repricing or amendment. The term “repricing” shall have the 

  

 16 

 
meaning given that term in Section 303A(8) of the New York Stock Exchange Listed Company Manual, as in effect from time to time. 
 (c) Termination of the Plan. No Awards shall be made after May 16, 2011. The Plan shall remain in effect thereafter in accordance with its
terms until such time as the Company has no further rights or obligations under the Plan with respect to outstanding Awards, unless the Plan is earlier terminated by the Board. 
 (d) Termination of 1998 Stock Incentive Plan. Effective November 16, 2004, the authority to grant new awards under the Company’s 1998
Stock Incentive Plan terminated. In other respects, the 1998 Stock Incentive Plan remains in effect in accordance with its terms with respect to outstanding awards. 
 22. Miscellaneous 
 (a) Stand-Alone, Additional, Tandem, and Substitute Awards. Awards may be
granted either alone or in addition to, in tandem with, or in substitution or exchange for, any other Award or any award granted under another plan of the Company or any business entity to be acquired by the Company, or any other right of a
Participant to receive payment from the Company. Such additional, tandem, and substituted or exchanged Awards may be granted at any time. The Committee may determine that, in granting a new Award, the intrinsic value of any surrendered Awards or
awards under another plan or issued by a business entity being acquired may be applied to reduce the Exercise Price of any Option, grant price of any SAR, or purchase price of any other Award. “Substitute Awards” shall include Awards
granted or shares of Stock issued by the Company in assumption of, or in substitution or exchange for, awards previously granted, or the right or obligation to make future awards, by a business entity acquired by the Company or with which the
Company combines. 
 (b) Compliance with Law and Stock Exchange Requirements. The Plan, the exercise of Options and SARs, and the
obligations of the Company to issue or transfer shares of Stock under Awards shall be subject to all applicable laws and stock exchange requirements and to approvals by any governmental or regulatory agency or stock exchange as may be required. With
respect to persons subject to Section 16 of the Exchange Act, it is the intent of the Company that the Plan and all transactions under the Plan comply with all applicable provisions of Rule 16b-3 or its successors under the Exchange Act. In
addition, it is the intent of the Company that Options designated Incentive Stock Options comply with the applicable provisions of Section 422 of the Code, that Awards intended to constitute “qualified performance-based awards” comply
with the applicable provisions of Section 162(m) of the Code and that Awards comply with applicable provisions of Section 409(A) of the Code. To the extent that any legal requirement of Section 16 of the Exchange Act or Sections 422,
162(m) or 409(A) of the Code as set forth in the Plan ceases to be required under Section 16 of the Exchange Act or Sections 422, 162(m) or 409(A) of the Code, that Plan provision shall cease to apply. The Committee may revoke any Award if it
is contrary to law, governmental regulation, or stock exchange requirements or modify an Award to bring it 

  

 17 

 
into compliance with any government regulation or stock exchange requirements. The Committee may agree to limit its authority under this subsection.

 (c) Enforceability. The Plan shall be binding upon and enforceable against the Company and its successors and assigns. 

(d) Unfunded Status of the Plan; Limitation on Rights. This Plan shall be unfunded. The Company shall not be required to establish any special
or separate fund or to make any other segregation of assets to ensure the payment of any Awards. Nothing contained in the Plan and no action taken pursuant hereto shall create or be construed to create a fiduciary relationship between the Company,
the Board, or the Committee and any Participant or any other person. No Participant or any other person shall under any circumstances acquire any property interest in any specific assets of the Company. To the extent that any person acquires a right
to receive payment from the Company hereunder, such right shall be no greater than the right of any unsecured general creditor of the Company. 
 (e) Rights of Participants. Nothing in this Plan shall entitle any Employee, Non-Employee Director or other person to claim a right to receive an Award. Neither this Plan nor any action taken hereunder shall be construed as giving
any individual any rights to be retained by or in the employment or service of the Company. 
 (f) No Fractional Shares. No fractional
shares of Stock shall be issued or delivered pursuant to any Award. The Committee shall determine whether cash, other Awards, or other property shall be issued or paid in lieu of such fractional shares or whether such fractional shares or any rights
thereto shall be forfeited or otherwise eliminated. 
 (g) Governing Law. The validity, construction, interpretation, and effect of
the Plan and Award Agreements shall be governed and construed by and determined in accordance with the laws of the State of Delaware, without giving effect to the conflict of laws provisions thereof. 
  

 18

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00118-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00118-of-00352.parquet"}]]